≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Dementia due to Parkinsons disease, excluding more controls

Endpoint Browser PheWeb

PD_DEMENTIA_EXMORE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
G6_PARKINSON, F5_PSYCH, NEURODIS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9967 4278 5570
Only index persons 8196 3544 4652
Unadjusted period prevalence (%)
Whole population 0.14 0.12 0.16
Only index persons 0.16 0.13 0.18
Median age at first event (years)
Whole population 77.63 78.85 76.70
Only index persons 77.59 78.87 76.63

-FinnGen-

Key figures

All Female Male
Number of individuals 965 348 617
Unadjusted period prevalence (%) 0.23 0.12 0.28
Median age at first event (years) 76.80 77.86 76.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
992
Matched controls
9920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
307.7
824
*
N06DA03
ATC
rivastigmine; oral, transdermal
2671.1
307.7
572
5
G20
ICD-10 Finland
Parkinson disease
4503599627370496.0
307.7
954
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
307.7
915
*
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
307.7
417
*
N87
ICPC
Parkinsonism
5325.2
307.7
480
*
N04BC05
ATC
pramipexole; oral
39.2
307.7
444
201
N04BD01
ATC
selegiline; oral
7607.1
307.7
449
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
17290.1
307.7
953
14
N05AH04
ATC
quetiapine; oral
76.8
307.7
501
130
AA1AD
NOMESCO Finland
CT of head and brain
9.7
288.5
503
948
N06DA02
ATC
donepezil; oral
149.3
283.0
141
11
N06DX01
ATC
memantine; oral
125.2
276.4
140
13
N04BC04
ATC
ropinirole; oral
3129.0
272.8
251
*
N04BD02
ATC
rasagiline; oral
3129.0
272.8
251
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
246.4
226
*
N03AE01
ATC
clonazepam; systemic
27.3
235.9
167
73
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
113.6
234.5
120
12
S06.0
ICD-10 Finland
Concussion
37.8
226.8
143
44
R25.1
ICD-10 Finland
Tremor, unspecified
35.4
222.3
143
47
193
Kela drug reimbursment
Rasagiline
+∞
221.4
204
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
100.9
208.1
108
12
R53
ICD-10 Finland
Malaise and fatigue
7.2
204.5
441
993
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.9
195.4
436
1009
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
49.3
174.3
102
23
I95.1
ICD-10 Finland
Orthostatic hypotension
13.4
172.3
175
156
N05AX08
ATC
risperidone; systemic
23.7
171.8
127
61
N04BX02
ATC
entacapone; oral
+∞
169.8
158
*
XA800
NOMESCO Finland
Neuropsychological investigation
77.0
169.1
91
13
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
5.7
164.3
533
1685
H02AA02
ATC
fludrocortisone; oral
57.4
157.2
89
17
N04BB01
ATC
amantadine; oral
31.5
146.8
97
34
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
140.0
131
*
N06AX11
ATC
mirtazapine; oral
5.4
139.2
380
1016
A28
ICPC
Limited function/disability NOS
5.3
137.2
397
1113
N06AB10
ATC
escitalopram; oral
8.7
136.0
193
269
F32.9
ICD-10 Finland
Depressive episode, unspecified
37.1
135.4
85
25
G47.3
ICD-10 Finland
Sleep apnoea
16.5
131.8
115
78
G04BD12
ATC
mirabegron; oral
5.9
127.9
290
654
L28
ICPC
Limited function/disability (L)
4.8
115.6
354
1021
SPAT1229
SPAT
Assessment of need for aid
8.0
113.2
170
251
S01.0
ICD-10 Finland
Open wound of scalp
7.6
112.9
179
281
A06AD11
ATC
lactulose; oral
4.9
112.6
330
917
N05BA04
ATC
oxazepam; oral
4.9
111.6
326
903
P20
ICPC
Memory disturbance
5.7
110.7
248
548
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
8.9
110.4
148
191
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
12.0
108.9
115
107
SPAT1216
SPAT
Assessment of functional ability
4.8
100.9
286
767
R41.0
ICD-10 Finland
Disorientation, unspecified
17.8
98.7
82
50
R4130
NOMESCO Finland
Speech therapy
23.5
95.7
70
32
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
999.1
94.5
91
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
55.9
93.2
53
10
N29
ICPC
Neurological sympt/complt other
33.5
93.1
60
19
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.2
91.3
148
236
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.6
89.5
260
705
N04BC09
ATC
rotigotine; transdermal
926.9
88.1
85
*
R1250
NOMESCO Finland
Evaluation of functional capability
21.1
87.7
67
34
N06AB04
ATC
citalopram; systemic
5.2
86.6
208
482
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
6.6
86.4
153
267
N28
ICPC
Limited function/disability (N)
34.2
85.9
55
17
Z2445
NOMESCO Finland
Psychologist
45.8
80.9
48
11
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
15.5
80.0
71
49
SPAT1234
SPAT
Support of social functional capacity
7.4
78.9
122
184
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.2
76.7
256
764
D21
ICPC
Swallowing problem
22.3
76.6
57
27
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
73.9
70
*
N05AH03
ATC
olanzapine; systemic
26.8
73.6
51
20
F03
ICD-10 Finland
Unspecified dementia
15.4
73.0
65
45
SPAT1215
SPAT
Assessment of need for medical rehabilitation
9.8
73.0
88
98
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.4
72.2
377
1509
WYA20
NOMESCO Finland
Home visit
20.7
71.7
55
28
S72.0
ICD-10 Finland
Fracture of neck of femur
6.5
71.4
126
218
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
15.1
71.3
64
45
N04AA02
ATC
biperiden; systemic
738.9
71.0
69
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
13.7
70.6
67
52
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.1
69.9
164
369
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.9
68.7
250
788
G30.1
ICD-10 Finland
Alzheimer disease with late onset
24.5
68.4
49
21
W19
ICD-10 Finland
Unspecified fall
5.2
68.3
155
339
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
68.1
448
2043
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.9
67.3
248
787
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.3
66.6
121
215
U04
ICPC
Incontinence urine
5.7
66.5
134
263
XF606
NOMESCO Finland
Ortostatic test
27.7
65.7
45
17
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
11.0
65.7
72
70
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.8
63.5
238
762
N06AX16
ATC
venlafaxine; oral
7.1
61.4
97
149
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
60.0
57
*
C07AA05
ATC
propranolol; systemic
4.0
59.1
194
564
F0232, G20,
ICD-10 Finland
+∞
58.9
56
*
A04
ICPC
Weakness/tiredness general
3.7
57.7
215
682
N04BX04
ATC
opicapone; oral
+∞
56.8
54
*
F0230, G20,
ICD-10 Finland
+∞
56.8
54
*
F05.9
ICD-10 Finland
Delirium, unspecified
156.6
56.5
59
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.7
56.3
145
350
SPAT1053
SPAT
Memory test
3.4
56.2
252
900
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
55.8
53
*
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
54.7
52
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.6
54.2
92
152
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
52.6
50
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
7.4
51.5
77
111
N19
ICPC
Speech disorder
98.9
51.4
56
6
N05BA06
ATC
lorazepam; systemic, sublingual
6.9
49.7
80
125
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
6.6
49.6
83
135
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.6
49.2
83
136
N06AX21
ATC
duloxetine; oral
5.9
48.8
93
172
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
10.9
48.5
53
51
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
9.0
48.1
61
72
R5110, ,
SPAT
4.1
47.2
144
394
N04BC06
ATC
cabergoline; oral
126.0
45.2
48
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
457.4
44.6
44
*
N30.0
ICD-10 Finland
Acute cystitis
3.3
44.4
200
708
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
44.1
42
*
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
+∞
44.1
42
*
SPAT1254
SPAT
Administration of medicine
3.2
43.8
202
725
R55
ICD-10 Finland
Syncope and collapse
3.5
43.5
173
566
N06AX26
ATC
vortioxetine; oral
10.7
42.5
47
46
N03AX12
ATC
[U] gabapentin; oral
3.6
41.7
156
490
N03AG01
ATC
valproic acid; systemic, rectal
70.3
41.4
47
7
G25.0
ICD-10 Finland
Essential tremor
10.7
40.7
45
44
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
5.5
39.8
80
155
R1260
NOMESCO Finland
Evaluation of communicative skills
12.6
39.5
39
32
S70.0
ICD-10 Finland
Contusion of hip
5.5
39.1
79
154
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
38.8
37
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
37.7
36
*
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
+∞
37.7
36
*
R35
ICD-10 Finland
Polyuria
3.9
37.6
122
347
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
13.9
37.5
35
26
P03
ICPC
Feeling depressed
9.2
37.4
46
52
SPAT1172
SPAT
Guidance concerning hydration
6.6
37.1
61
97
NA1AD
NOMESCO Finland
Cervical spine CT examination
6.3
36.8
64
108
N04BC02
ATC
pergolide; oral
+∞
36.7
35
*
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
7.7
36.3
52
71
N02AA05
ATC
oxycodone; systemic
2.6
36.2
287
1363
R41.3
ICD-10 Finland
Other amnesia
9.5
35.9
43
47
G02CB01
ATC
bromocriptine; systemic
61.0
35.4
41
7
G40.9
ICD-10 Finland
Epilepsy, unspecified
186.6
35.0
36
*
M48.0
ICD-10 Finland
Spinal stenosis
3.1
34.7
165
598
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.1
34.4
35
30
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.6
34.1
44
53
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.4
33.8
57
93
E86
ICD-10 Finland
Volume depletion
6.5
33.4
56
91
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.3
33.3
70
141
K59.0
ICD-10 Finland
Constipation
4.2
32.5
91
232
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
32.5
31
*
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
327.1
32.0
32
*
P29
ICPC
Psychological sympt/compl other
11.7
31.9
33
29
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
322.6
31.0
31
*
SPAT1305
SPAT
Counselling and guidance related to physical exercise
3.3
30.0
122
401
R44.1
ICD-10 Finland
Visual hallucinations
85.3
29.9
33
*
N03AX16
ATC
[U] pregabalin
2.6
29.8
200
867
I95.9
ICD-10 Finland
Hypotension, unspecified
8.7
29.8
38
45
K90
ICPC
Stroke/cerebrovascular accident
41.5
29.1
36
9
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
10.6
29.0
32
31
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
7.3
29.0
43
61
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
300.4
28.9
29
*
N99
ICPC
Neurological disease other
45.2
28.8
35
8
Z75.5
ICD-10 Finland
Holiday relief care
45.2
28.8
35
8
N06AX03
ATC
mianserin; oral
7.0
28.6
44
65
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.3
28.4
118
393
SPAT1167
SPAT
Insertion of urinary catheter
4.5
28.1
72
171
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
3.0
27.9
134
486
G30.8
ICD-10 Finland
Other Alzheimer disease
103.1
27.8
30
*
G04BD11
ATC
fesoterodine; oral
5.2
27.3
58
118
R42
ICD-10 Finland
Dizziness and giddiness
2.4
27.2
238
1164
SPAT1301
SPAT
No procedures
2.2
27.1
338
1912
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
27.1
108
350
G72.8
ICD-10 Finland
Other specified myopathies
143.9
26.8
28
*
G04BD09
ATC
trospium; oral
6.1
26.7
47
80
N02BE01
ATC
paracetamol; systemic, rectal
2.6
26.4
849
6863
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
26.3
134
502
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
+∞
26.2
25
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
26.2
25
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.5
25.9
43
69
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
25.7
273
1445
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
25.6
188
847
R13
ICD-10 Finland
Dysphagia
3.7
25.3
86
251
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
25.1
107
361
R32
ICD-10 Finland
Unspecified urinary incontinence
5.8
25.1
47
85
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
+∞
25.1
24
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
71.8
24.9
28
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.6
24.9
85
249
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.7
24.7
35
47
P70
ICPC
Dementia
20.7
24.5
36
18
N06AB06
ATC
sertraline; oral
4.8
24.1
55
119
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
+∞
24.1
23
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
24.1
23
*
TAB00
NOMESCO Finland
Lumbar puncture
9.3
23.9
29
32
R47.1
ICD-10 Finland
Dysarthria and anarthria
69.2
23.9
27
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
8.8
23.7
30
35
N05CF01
ATC
zopiclone; oral
2.1
23.7
311
1778
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
6.4
23.3
39
63
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.6
23.2
145
603
N05AH02
ATC
clozapine; systemic
+∞
23.0
22
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
23.0
22
*
R23
ICPC
Voice symptom/complaint
7.5
22.1
32
44
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.7
22.0
28
33
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
+∞
22.0
21
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
22.0
21
*
SPAT1240
SPAT
Therapeutic discussion
5.4
21.9
44
85
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
18.9
21.8
33
18
J01EA01
ATC
trimethoprim; systemic
2.1
21.8
262
1444
F05.8
ICD-10 Finland
Other delirium
82.0
21.8
24
*
F22.0
ICD-10 Finland
Delusional disorder
224.8
21.7
22
*
J01CA08
ATC
pivmecillinam; oral
2.0
21.5
316
1873
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.4
21.4
43
83
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.5
21.3
76
229
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
21.0
157
3011
N05BA01
ATC
diazepam; systemic, rectal
2.8
21.0
117
458
F0234, G20,
ICD-10 Finland
+∞
20.9
20
*
Y94.0
ICD-10 Finland
Accident at home
7.0
20.9
32
47
S01.9
ICD-10 Finland
Open wound of head, part unspecified
7.5
20.9
30
41
N06DA04
ATC
galantamine; oral
78.5
20.8
23
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.1
20.7
89
301
UKC02
NOMESCO Finland
Cystoscopy
2.1
20.4
237
1286
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
20.1
157
722
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
20.1
146
650
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
19.9
19
*
N05CD07
ATC
temazepam; oral
2.5
19.7
135
585
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
19.6
427
2863
XKD00
NOMESCO Finland
Uroflowmetry
2.0
19.5
255
1442
G04BD08
ATC
solifenacin; oral
3.1
19.2
86
298
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
+∞
18.8
18
*
SPAT1262
SPAT
Handing over of treatment supplies
2.2
18.7
193
996
S00.0
ICD-10 Finland
Superficial injury of scalp
6.0
18.5
33
57
Z3226
NOMESCO Finland
Physiotherapist
2.2
18.2
179
906
P01
ICPC
Feeling anxious/nervous/tense
5.6
18.0
34
62
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
17.9
148
697
F06.7
ICD-10 Finland
Mild cognitive disorder
7.1
17.9
27
39
SPAT1360
SPAT
Extensive global examination
3.0
17.9
85
305
A29
ICPC
General symptom/complaint other
2.3
17.8
153
732
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
17.8
17
*
130
Kela drug reimbursment
Malignant tumour
0.1
17.7
16
1010
SPAT1125
SPAT
Stoma care and guidance
5.4
17.6
35
67
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
17.3
162
803
S72.1
ICD-10 Finland
Pertrochanteric fracture
4.3
17.1
45
109
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
17.1
160
792
R1250, ,
SPAT
5.1
17.0
36
73
M54.5
ICD-10 Finland
Low back pain
1.9
16.9
262
1561
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
16.9
270
1625
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
16.7
16
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
16.7
16
*
R06.5
ICD-10 Finland
Mouth breathing
4.1
16.7
47
120
SPAT1050
SPAT
Extensive neurological examination
6.8
16.6
26
39
AXX01
NOMESCO Finland
Memory assessment
28.1
16.5
22
8
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
172.8
16.5
17
*
G44.2
ICD-10 Finland
Tension-type headache
3.5
16.4
57
169
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
15.7
16.2
26
17
R33
ICD-10 Finland
Retention of urine
2.3
16.1
128
592
ICB01, ,
SPAT
48.3
16.1
19
*
S22.3
ICD-10 Finland
Fracture of rib
2.9
16.0
80
295
SPAT1263
SPAT
Sampling
1.8
15.9
366
2456
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
15.9
96
390
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
15.8
76
274
N06AA12
ATC
doxepin; systemic
3.7
15.8
50
139
R60.0
ICD-10 Finland
Localized oedema
2.2
15.7
146
720
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
15.7
15
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
15.7
15
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
15.7
15
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
15.5
206
1161
K91
ICPC
Cerebrovascular disease
38.7
15.4
19
5
S20.2
ICD-10 Finland
Contusion of thorax
3.5
15.4
54
161
J01DB01
ATC
cefalexin; oral
1.8
15.3
705
5726
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.2
15.2
26
43
D12
ICPC
Constipation
3.4
15.1
56
173
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
14.9
93
384
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
6.0
14.8
26
44
WX212
NOMESCO Finland
Femoral plexus blockade
4.2
14.8
40
99
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
18.7
14.7
22
12
N03AF02
ATC
oxcarbazepine; oral
21.4
14.7
21
10
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
5.2
14.6
30
59
N86
ICPC
Multiple sclerosis
+∞
14.6
14
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
+∞
14.6
14
*
G04CB01
ATC
finasteride; oral
2.0
14.5
193
1086
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
152.2
14.5
15
*
G04CA02
ATC
tamsulosin; oral
1.7
14.5
351
2377
T36
ICD-10 Finland
Poisoning by systemic antibiotics
17.3
14.3
22
13
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
22.6
14.3
20
9
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.3
14.2
37
89
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
14.0
53
166
Z50.5
ICD-10 Finland
Speech therapy
17.8
13.9
21
12
N06AA09
ATC
amitriptyline; systemic
2.9
13.8
66
237
F023, G20,
ICD-10 Finland
+∞
13.6
13
*
F06.0
ICD-10 Finland
Organic hallucinosis
+∞
13.6
13
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
13.6
13
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
13.6
13
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
13.6
13
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
13.6
13
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
141.9
13.5
14
*
N06AX12
ATC
bupropion; oral
13.1
13.4
23
18
ZXD35
NOMESCO Finland
Usual procedure
3.9
13.4
39
102
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.5
13.4
33
76
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
13.4
129
644
A01
ICPC
Pain general/multiple sites
2.5
13.4
89
379
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
21.5
13.4
19
9
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
12.4
13.1
23
19
N06AB03
ATC
fluoxetine; oral
2.8
13.1
66
244
B01AC07
ATC
dipyridamole; systemic
2.9
13.0
61
217
F01.9
ICD-10 Finland
Vascular dementia, unspecified
28.8
13.0
17
6
SPAT1304
SPAT
Counselling and guidance related to ageing
2.3
13.0
105
488
N05BA12
ATC
alprazolam; oral
2.7
12.9
70
269
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.7
12.9
40
110
R4110, ,
SPAT
2.2
12.6
116
568
R4120
NOMESCO Finland
Occupational therapy
3.5
12.6
44
131
SPAT1139
SPAT
Nutrition survey
3.9
12.5
37
98
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
12.5
12
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
20.3
12.5
18
9
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
131.6
12.5
13
*
S63.1
ICD-10 Finland
Dislocation of finger
5.4
12.3
24
45
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
12.3
268
1747
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
10.7
12.3
23
22
R30.1
ICD-10 Finland
Vesical tenesmus
5.2
12.3
25
49
ACC51
NOMESCO Finland
Release of median nerve
38.0
12.2
15
*
SPAT1244
SPAT
Occupational therapy
18.3
12.1
18
10
SPAT1260
SPAT
Consultation of another employee
1.9
12.1
162
911
N03AX14
ATC
levetiracetam; systemic
21.6
12.0
17
8
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
11.9
51
172
C03CA01
ATC
furosemide; systemic
1.6
11.8
422
3122
R4120, ,
SPAT
12.7
11.7
20
16
F34.1
ICD-10 Finland
Dysthymia
65.7
11.6
13
*
R4130, ,
SPAT
65.7
11.6
13
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
+∞
11.5
11
*
I63.8
ICD-10 Finland
Other cerebral infarction
+∞
11.5
11
*
N04BC01
ATC
bromocriptine; oral
+∞
11.5
11
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
11.5
11
*
F0029, G308,
ICD-10 Finland
+∞
11.5
11
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
11.5
11
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
+∞
11.5
11
*
N04BX01
ATC
tolcapone; oral
+∞
11.5
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.6
11.5
375
2709
A03FA01
ATC
metoclopramide; systemic, rectal
0.4
11.5
75
1580
N05AX12
ATC
aripiprazole; systemic
121.4
11.4
12
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
121.4
11.4
12
*
M01AC06
ATC
meloxicam; systemic, rectal
1.7
11.4
283
1906
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
11.4
89
407
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
4.2
11.4
30
73
SPAT1279
SPAT
Preparation of immediate hospitalisation
5.5
11.4
22
41
S01.3
ICD-10 Finland
Open wound of ear
12.0
11.4
20
17
R2110
NOMESCO Finland
Giving the first information
2.8
11.3
58
217
S01.8
ICD-10 Finland
Open wound of other parts of head
4.8
11.2
25
53
H02AB02
ATC
dexamethasone; systemic
0.3
11.2
26
898
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.5
11.2
38
111
W17
ICD-10 Finland
Other fall from one level to another
3.5
11.2
39
116
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
11.1
*
336
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.1
342
2432
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.8
11.0
34
93
SPAT1101
SPAT
Orthostatic test
2.9
11.0
52
186
A02BC05
ATC
esomeprazole; systemic
1.6
11.0
318
2224
N18
ICPC
Paralysis/weakness
14.1
11.0
18
13
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
43.8
10.9
13
*
R44.3
ICD-10 Finland
Hallucinations, unspecified
43.8
10.9
13
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.9
10.9
50
176
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
10.9
60
233
S01
ICD-10 Finland
Open wound of head
8.4
10.8
23
28
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.1
10.8
*
327
F32.1
ICD-10 Finland
Moderate depressive episode
28.4
10.7
14
5
S09.9
ICD-10 Finland
Unspecified injury of head
5.6
10.7
20
36
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.7
169
999
G04BD07
ATC
tolterodine; oral
2.7
10.7
57
218
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
60.7
10.6
12
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
4.7
10.5
24
52
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.7
10.5
24
52
OAB76
NOMESCO Finland
General guidance on nutrition and food
+∞
10.4
10
*
F0231, G20,
ICD-10 Finland
+∞
10.4
10
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
10.4
10
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
+∞
10.4
10
*
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
10.4
10
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
10.4
10
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
10.4
111
575
R5130, ,
SPAT
16.2
10.4
16
10
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.8
10.4
53
198
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
32.9
10.3
13
*
N03AX09
ATC
lamotrigine; oral
32.9
10.3
13
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
19.0
10.3
15
8
NF3AA
NOMESCO Finland
Femur X-ray examination
3.6
10.3
33
93
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
4.9
10.0
22
46
F32
ICD-10 Finland
Depressive episode
9.3
10.0
20
22
H50.52
ICD-10 Finland
Exophoria
10.2
10.0
19
19
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
10.0
325
2327
M01AH02
ATC
rofecoxib; oral
2.0
10.0
124
677
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.9
10.0
29
76
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
10.0
67
287
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
16.9
9.9
15
9
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
9.9
118
636
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
4.4
9.8
24
55
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
9.8
109
573
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.8
258
1755
N05AB03
ATC
perphenazine; systemic, rectal
13.5
9.7
16
12
IGY02
NOMESCO Finland
Psychiatric monitoring contact
55.5
9.7
11
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
55.5
9.7
11
*
A02BC01
ATC
omeprazole; systemic
1.6
9.6
247
1669
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
8.5
9.6
20
24
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
9.2
9.5
19
21
M79.6
ICD-10 Finland
Pain in limb
1.6
9.5
307
2192
H53.2
ICD-10 Finland
Diplopia
3.7
9.4
30
84
G30.0
ICD-10 Finland
Alzheimer disease with early onset
101.0
9.4
10
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
101.0
9.4
10
*
N05AF03
ATC
chlorprothixene; systemic
30.3
9.4
12
*
N04AA01
ATC
trihexyphenidyl; oral
+∞
9.4
9
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
9.4
9
*
G21.8
ICD-10 Finland
Other secondary parkinsonism
+∞
9.4
9
*
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
+∞
9.4
9
*
F41.09
ICD-10 Finland
UNS Panic Syndrome
+∞
9.4
9
*
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
9.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
9.4
256
1755
N06AG02
ATC
moclobemide; oral
4.0
9.4
26
66
E0000UV, ,
ATC
1.6
9.4
326
2366
L01BC06
ATC
capecitabine; oral
0.1
9.1
*
310
M03BX01
ATC
baclofen; systemic
15.7
9.0
14
9
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.5
9.0
30
87
G25.2
ICD-10 Finland
Other specified forms of tremor
18.8
8.9
13
7
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
24.3
8.9
12
5
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
4.0
8.9
25
64
XQ855, ,
SPAT
4.9
8.9
19
39
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.7
8.8
27
74
G04BD04
ATC
oxybutynin; oral, transdermal
2.4
8.7
60
260
R1430, ,
SPAT
7.7
8.7
19
25
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
7.7
8.7
19
25
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.8
8.7
26
70
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
8.6
324
2383
G04BD10
ATC
darifenacin; oral
11.7
8.6
15
13
Z3231
NOMESCO Finland
Registered nurse
1.6
8.6
242
1668
RF120, ,
NOMESCO Finland
9.1
8.6
17
19
N05BE01
ATC
buspirone; oral
10.1
8.5
16
16
L84
ICD-10 Finland
Corns and callosities
3.0
8.5
36
121
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
8.5
115
646
N17
ICPC
Vertigo/dizziness
1.9
8.5
117
661
F43.29
ICD-10 Finland
Adaptation disorder UNS
27.8
8.5
11
*
R4110
NOMESCO Finland
Physiotherapy
1.6
8.4
246
1708
K11.72
ICD-10 Finland
Xerostomia
90.8
8.4
9
*
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
90.8
8.4
9
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
90.8
8.4
9
*
N05AN01
ATC
lithium; oral
90.8
8.4
9
*
ZXA00
NOMESCO Finland
Right side
1.6
8.4
249
1735
TPH04, ,
SPAT
4.9
8.4
18
37
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.7
8.4
19
41
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
+∞
8.3
8
*
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
+∞
8.3
8
*
N04BC07
ATC
apomorphine; parenteral
+∞
8.3
8
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
8.3
8
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.3
8
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
8.3
8
*
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.8
8.3
42
156
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.1
8.2
*
310
S80.0
ICD-10 Finland
Contusion of knee
2.6
8.2
45
175
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.2
8.1
17
21
ZY000
NOMESCO Finland
Hospital inpatient
33.6
8.1
10
*
F32.8
ICD-10 Finland
Other depressive episodes
33.6
8.1
10
*
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
33.6
8.1
10
*
Z29
ICPC
Social problem NOS
6.4
8.0
20
32
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
8.0
83
425
N08
ICPC
Abnormal involuntary movements
22.2
8.0
11
5
G56.2
ICD-10 Finland
Lesion of ulnar nerve
22.2
8.0
11
5
L03
ICPC
Low back symptom/complaint
1.6
8.0
187
1230
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
7.9
66
311
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
7.9
471
3788
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.3
7.8
29
90
S50.0
ICD-10 Finland
Contusion of elbow
3.7
7.8
24
66
SPAT1138
SPAT
Guidance concerning bowel function
4.4
7.7
19
44
L12.0
ICD-10 Finland
Bullous pemphigoid
7.5
7.7
17
23
S28
ICPC
Limited function/disability (S)
8.1
7.6
16
20
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
12.0
7.6
13
11
M54
ICD-10 Finland
Dorsalgia
2.0
7.6
77
392
R1100, ,
SPAT
6.2
7.6
19
31
PA6AD
NOMESCO Finland
CT of neck arteries
4.5
7.4
18
41
P76
ICPC
Depressive disorder
6.5
7.4
18
28
LAITO, ,
NOMESCO Finland
80.7
7.4
8
*
S06.3
ICD-10 Finland
Focal brain injury
80.7
7.4
8
*
G55.2
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
80.7
7.4
8
*
H50.31
ICD-10 Finland
Intermittent exotropia
13.5
7.4
12
9
L02
ICPC
Back symptom/complaint
2.2
7.4
62
293
N05CF02
ATC
zolpidem; oral
1.9
7.4
99
555
WYA20, ,
SPAT
6.9
7.3
17
25
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
+∞
7.3
7
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
+∞
7.3
7
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
+∞
7.3
7
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
+∞
7.3
7
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
+∞
7.3
7
*
F02.33
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly depression
+∞
7.3
7
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
7.3
7
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
7.3
7
*
AA052, ,
NOMESCO Finland
+∞
7.3
7
*
F0009, G300,
ICD-10 Finland
+∞
7.3
7
*
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.3
7.3
27
84
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.2
262
1900
WX320
NOMESCO Finland
Spinalanesthesy
1.5
7.2
231
1631
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.7
7.2
22
60
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.6
7.2
23
65
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.7
7.1
37
140
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
12.1
7.1
12
10
SPAT1246
SPAT
Screening of depression or other psychiatric problem
8.9
7.1
14
16
M43.1
ICD-10 Finland
Spondylolisthesis
3.1
7.1
28
91
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
7.1
86
467
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.1
7.1
*
281
E87.6
ICD-10 Finland
Hypokalaemia
2.6
7.0
38
147
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
7.0
44
183
Z50.1
ICD-10 Finland
Other physical therapy
2.3
7.0
49
215
K56.2
ICD-10 Finland
Volvulus
6.4
7.0
17
27
R5140, ,
SPAT
6.4
7.0
17
27
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.9
6.9
31
108
H02BX01
ATC
methylprednisolone, combinations; systemic
2.2
6.9
55
254
SPAT1252
SPAT
Overall medication plan or its review
2.1
6.9
67
335
N30
ICD-10 Finland
Cystitis
2.2
6.9
56
261
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
6.9
24
72
M03BX02
ATC
tizanidine; oral
1.4
6.8
376
2955
J01CA04
ATC
amoxicillin; systemic
1.4
6.8
646
5598
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
6.8
106
623
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.8
367
2875
R40.0
ICD-10 Finland
Somnolence
40.3
6.8
8
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
40.3
6.8
8
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
40.3
6.8
8
*
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
16.8
6.8
10
6
W10
ICD-10 Finland
Fall on and from stairs and steps
2.6
6.8
39
156
L99
ICPC
Musculoskeletal disease other
3.5
6.7
22
63
L76
ICPC
Fracture: other
2.9
6.7
31
110
W06
ICD-10 Finland
Fall involving bed
7.2
6.7
15
21
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
22.7
6.7
9
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
22.7
6.7
9
*
G04CB02
ATC
dutasteride; oral
1.7
6.7
113
680
XKC03
NOMESCO Finland
Water cystometry
3.2
6.6
26
84
F03
ICPC
Eye discharge
2.3
6.6
51
233
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
3.2
6.6
25
79
G43.9
ICD-10 Finland
Migraine, unspecified
12.3
6.6
11
9
G45.4
ICD-10 Finland
Transient global amnesia
10.1
6.5
12
12
A08
ICPC
Swelling
2.1
6.5
57
274
A02BC02
ATC
pantoprazole; systemic
1.4
6.5
581
4958
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.2
6.5
16
26
L29
ICPC
Musculoskeletal sympt/complt other
2.0
6.5
71
372
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
70.3
6.4
7
*
G72.9
ICD-10 Finland
Myopathy, unspecified
70.3
6.4
7
*
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
70.3
6.4
7
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
70.3
6.4
7
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
70.3
6.4
7
*
R26
ICD-10 Finland
Abnormalities of gait and mobility
70.3
6.4
7
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
70.3
6.4
7
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
6.4
133
845
F41.1
ICD-10 Finland
Generalized anxiety disorder
14.4
6.4
10
7
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
14.4
6.4
10
7
N80
ICPC
Head injury other
4.1
6.4
17
42
S70.1
ICD-10 Finland
Contusion of thigh
4.1
6.4
17
42
ZX120, ,
SPAT
4.1
6.4
17
42
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
6.4
79
1360
N03AF01
ATC
carbamazepine; oral, rectal
3.1
6.3
25
81
WF002
NOMESCO Finland
Radical radiotherapy
0.2
6.3
11
451
R07.3
ICD-10 Finland
Other chest pain
1.9
6.3
75
404
359
Kela drug reimbursment
Mirabegroni
11.1
6.3
11
10
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
9.3
6.3
12
13
K08.3
ICD-10 Finland
Retained dental root
2.0
6.3
69
362
F0019, G301,
ICD-10 Finland
+∞
6.3
6
*
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
6.3
6
*
WX723
NOMESCO Finland
CPAP therapy
+∞
6.3
6
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
6.3
6
*
F06.32
ICD-10 Finland
Organic depression
+∞
6.3
6
*
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
+∞
6.3
6
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
6.3
6
*
N88
ICPC
Epilepsy
+∞
6.3
6
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
6.3
6
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
6.3
6
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
+∞
6.3
6
*
F009, G309,
ICD-10 Finland
+∞
6.3
6
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
26.9
6.2
8
*
A06AX04
ATC
linaclotide; oral
26.9
6.2
8
*
OAB48
NOMESCO Finland
Lifestyle advice and guidance
26.9
6.2
8
*
Z60.8
ICD-10 Finland
Other problems related to social environment
26.9
6.2
8
*
SCA02
NOMESCO Finland
Preventive oral health care
2.1
6.2
59
293
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.2
119
741
S00.8
ICD-10 Finland
Superficial injury of other parts of head
5.1
6.2
18
36
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.6
6.2
20
57
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
6.2
117
726
AA1AA
NOMESCO Finland
Head X-ray examination
6.3
6.2
15
24
SPAT1014
SPAT
Treatment of eyes
3.4
6.2
21
62
N02BF01
ATC
gabapentin; oral
2.1
6.1
56
274
B03BA03
ATC
hydroxocobalamin; parenteral
2.0
6.1
66
344
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.2
6.1
16
39
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
12.6
6.1
10
8
Z51.5
ICD-10 Finland
Palliative care
1.7
6.1
124
785
-, ,
ICD-10 Finland
3.1
6.1
24
78
SPAT1127
SPAT
Enema
6.7
6.0
14
21
K89
ICPC
Transient cerebral ischaemia
10.1
6.0
11
11
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.9
6.0
28
100
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.5
6.0
20
58
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.9
6.0
17
44

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurology
13 [38004458]
5.1e+00
5.6e+00
4.9e+00
1.0e+50
5.6e+00
5.4e+00
4.5e+00
cases:78.93%
controls:2.30%
cases:68.95%
controls:0.83%
cases:16.63%
controls:0.14%
cases:43.35%
controls:0.00%
cases:18.35%
controls:0.08%
cases:64.31%
controls:0.80%
cases:71.82%
controls:2.76%
783
228
209
9685
684
82
308
9831
165
14
827
9899
430
0
562
9913
178
8
792
9853
546
74
303
9156
311
175
122
6168
quetiapine; oral
N05AH04 [21604544]
3.7e+00
4.5e+00
4.6e+00
1.0e+50
5.0e+00
4.6e+00
4.5e+00
cases:15.02%
controls:0.42%
cases:21.67%
controls:0.29%
cases:8.87%
controls:0.10%
cases:0.60%
controls:0.00%
cases:10.31%
controls:0.08%
cases:29.80%
controls:0.41%
cases:41.34%
controls:0.79%
149
42
843
9871
215
29
777
9884
88
10
904
9903
6
0
986
9913
100
8
870
9853
253
38
596
9192
179
50
254
6293
pramipexole; oral
N04BC05 [21604477]
4.1e+00
3.9e+00
3.3e+00
1.0e+50
3.7e+00
3.4e+00
3.0e+00
cases:31.05%
controls:0.76%
cases:20.56%
controls:0.52%
cases:6.25%
controls:0.25%
cases:1.11%
controls:0.00%
cases:5.98%
controls:0.16%
cases:13.66%
controls:0.53%
cases:15.94%
controls:0.95%
308
75
684
9838
204
52
788
9861
62
25
930
9888
11
0
981
9913
58
16
912
9845
116
49
733
9181
69
60
364
6283
Support of social functional capacity
SPAT1234 [2001700335]
2.6e+00
3.3e+00
3.6e+00
2.8e+00
3.5e+00
3.0e+00
2.4e+00
cases:4.23%
controls:0.34%
cases:5.04%
controls:0.20%
cases:3.83%
controls:0.11%
cases:1.01%
controls:0.06%
cases:3.71%
controls:0.12%
cases:6.12%
controls:0.33%
cases:10.16%
controls:1.06%
42
34
950
9879
50
20
942
9893
38
11
954
9902
10
6
982
9907
36
12
934
9849
52
30
797
9200
44
67
389
6276
In Home Supportive Care Agency
253Z00000X [38004206]
2.6e+00
2.8e+00
3.2e+00
3.0e+00
3.0e+00
2.9e+00
2.3e+00
cases:3.83%
controls:0.28%
cases:5.14%
controls:0.34%
cases:3.53%
controls:0.15%
cases:1.21%
controls:0.06%
cases:3.40%
controls:0.17%
cases:6.12%
controls:0.37%
cases:9.24%
controls:1.06%
38
28
954
9885
51
34
941
9879
35
15
957
9898
12
6
980
9907
33
17
937
9844
52
34
797
9196
40
67
393
6276
risperidone; oral, parenteral
N05AX08 [21604559]
3.4e+00
3.9e+00
3.0e+00
—
2.8e+00
3.2e+00
3.2e+00
cases:2.92%
controls:0.10%
cases:3.73%
controls:0.08%
cases:1.01%
controls:0.05%
—
—
cases:1.03%
controls:0.06%
cases:3.77%
controls:0.16%
cases:7.39%
controls:0.33%
29
10
963
9903
37
8
955
9905
10
5
982
9908
—
10
6
960
9855
32
15
817
9215
32
21
401
6322
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
2.4e+00
2.8e+00
3.0e+00
3.2e+00
2.8e+00
2.9e+00
1.9e+00
cases:4.23%
controls:0.38%
cases:6.15%
controls:0.40%
cases:5.14%
controls:0.26%
cases:1.41%
controls:0.06%
cases:4.43%
controls:0.28%
cases:8.24%
controls:0.48%
cases:11.55%
controls:1.97%
42
38
950
9875
61
40
931
9873
51
26
941
9887
14
6
978
9907
43
28
927
9833
70
44
779
9186
50
125
383
6218
Functional capacity evaluation
443351003 [40481051]
1.9e+00
2.5e+00
3.2e+00
3.1e+00
3.0e+00
2.5e+00
1.7e+00
cases:14.62%
controls:2.59%
cases:9.78%
controls:0.91%
cases:4.94%
controls:0.21%
cases:1.11%
controls:0.05%
cases:4.95%
controls:0.26%
cases:10.60%
controls:0.98%
cases:18.48%
controls:3.99%
145
257
847
9656
97
90
895
9823
49
21
943
9892
11
5
981
9908
48
26
922
9835
90
90
759
9140
80
253
353
6090
venlafaxine; oral
N06AX16 [21604745]
3.1e+00
3.0e+00
3.3e+00
—
2.9e+00
2.6e+00
2.8e+00
cases:4.44%
controls:0.20%
cases:2.92%
controls:0.15%
cases:1.61%
controls:0.06%
—
—
cases:1.13%
controls:0.06%
cases:2.59%
controls:0.20%
cases:3.46%
controls:0.22%
44
20
948
9893
29
15
963
9898
16
6
976
9907
—
11
6
959
9855
22
18
827
9212
15
14
418
6329
Guidance concerning hydration
SPAT1172 [2001700273]
2.6e+00
3.1e+00
3.8e+00
—
2.8e+00
3.0e+00
2.1e+00
cases:1.92%
controls:0.15%
cases:3.33%
controls:0.15%
cases:2.22%
controls:0.05%
—
—
cases:1.13%
controls:0.07%
cases:3.30%
controls:0.17%
cases:5.08%
controls:0.63%
19
15
973
9898
33
15
959
9898
22
5
970
9908
—
11
7
959
9854
28
16
821
9214
22
40
411
6303
Home Visit
OMOP4822459 [581476]
2.0e+00
2.5e+00
2.6e+00
2.6e+00
2.8e+00
2.6e+00
2.1e+00
cases:30.95%
controls:5.76%
cases:30.65%
controls:3.67%
cases:15.32%
controls:1.28%
cases:6.25%
controls:0.47%
cases:17.53%
controls:1.29%
cases:38.28%
controls:4.50%
cases:55.43%
controls:13.45%
307
571
685
9342
304
364
688
9549
152
127
840
9786
62
47
930
9866
170
127
800
9734
325
415
524
8815
240
853
193
5490
Inpatient Hospital
21 [8717]
9.3e-01
1.4e+00
2.4e+00
6.9e+00
2.4e+00
1.7e+00
1.2e+00
cases:52.32%
controls:30.25%
cases:32.56%
controls:10.33%
cases:15.12%
controls:1.53%
cases:34.27%
controls:0.05%
cases:14.95%
controls:1.62%
cases:39.10%
controls:10.53%
cases:53.81%
controls:25.27%
519
2999
473
6914
323
1024
669
8889
150
152
842
9761
340
5
652
9908
145
160
825
9701
332
972
517
8258
233
1603
200
4740
clonazepam; oral, parenteral
N03AE01 [21604415]
3.8e+00
4.6e+00
1.0e+50
—
1.0e+50
4.4e+00
4.0e+00
cases:7.06%
controls:0.16%
cases:4.94%
controls:0.05%
cases:1.31%
controls:0.00%
—
—
cases:0.93%
controls:0.00%
cases:4.95%
controls:0.07%
cases:8.08%
controls:0.16%
70
16
922
9897
49
5
943
9908
13
0
979
9913
—
9
0
961
9861
42
6
807
9224
35
10
398
6333
escitalopram; oral
N06AB10 [21604718]
2.5e+00
2.7e+00
3.3e+00
—
3.3e+00
2.5e+00
2.4e+00
cases:8.47%
controls:0.78%
cases:6.45%
controls:0.45%
cases:2.72%
controls:0.10%
—
—
cases:3.09%
controls:0.12%
cases:6.24%
controls:0.52%
cases:10.39%
controls:1.01%
84
77
908
9836
64
45
928
9868
27
10
965
9903
—
30
12
940
9849
53
48
796
9182
45
64
388
6279
colecalciferol; oral
A11CC05 [21600820]
2.4e+00
2.5e+00
3.1e+00
—
2.7e+00
2.7e+00
3.0e+00
cases:2.62%
controls:0.23%
cases:3.63%
controls:0.30%
cases:2.42%
controls:0.11%
—
—
cases:2.47%
controls:0.16%
cases:5.54%
controls:0.39%
cases:10.16%
controls:0.55%
26
23
966
9890
36
30
956
9883
24
11
968
9902
—
24
16
946
9845
47
36
802
9194
44
35
389
6308
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
1.5e+00
2.2e+00
2.9e+00
2.6e+00
2.8e+00
2.1e+00
1.5e+00
cases:10.18%
controls:2.36%
cases:8.17%
controls:0.99%
cases:5.95%
controls:0.36%
cases:1.51%
controls:0.11%
cases:5.77%
controls:0.37%
cases:10.01%
controls:1.33%
cases:16.40%
controls:4.11%
101
234
891
9679
81
98
911
9815
59
36
933
9877
15
11
977
9902
56
36
914
9825
85
123
764
9107
71
261
362
6082
Limited function/disability NOS
A28 [2002000162]
1.9e+00
2.3e+00
2.5e+00
2.8e+00
2.5e+00
2.2e+00
1.5e+00
cases:14.31%
controls:2.49%
cases:13.91%
controls:1.61%
cases:6.45%
controls:0.54%
cases:2.32%
controls:0.15%
cases:7.53%
controls:0.68%
cases:16.14%
controls:1.99%
cases:22.17%
controls:6.23%
142
247
850
9666
138
160
854
9753
64
54
928
9859
23
15
969
9898
73
67
897
9794
137
184
712
9046
96
395
337
5948
Administration of medicine
SPAT1254 [2001700355]
1.4e+00
2.0e+00
2.8e+00
2.9e+00
2.7e+00
2.3e+00
1.4e+00
cases:7.36%
controls:1.96%
cases:6.75%
controls:1.00%
cases:5.85%
controls:0.36%
cases:2.12%
controls:0.12%
cases:5.57%
controls:0.40%
cases:9.54%
controls:1.05%
cases:13.86%
controls:3.89%
73
194
919
9719
67
99
925
9814
58
36
934
9877
21
12
971
9901
54
39
916
9822
81
97
768
9133
60
247
373
6096
macrogol; oral
A06AD15 [21600575]
1.9e+00
2.1e+00
3.3e+00
—
2.8e+00
2.8e+00
2.5e+00
cases:6.25%
controls:1.00%
cases:4.13%
controls:0.54%
cases:1.31%
controls:0.05%
—
—
cases:1.55%
controls:0.09%
cases:9.54%
controls:0.63%
cases:20.55%
controls:2.14%
62
99
930
9814
41
54
951
9859
13
5
979
9908
—
15
9
955
9852
81
58
768
9172
89
136
344
6207
Nursing episode
950 [44777714]
1.6e+00
2.1e+00
2.4e+00
2.4e+00
2.6e+00
2.2e+00
2.0e+00
cases:10.69%
controls:2.35%
cases:11.90%
controls:1.56%
cases:5.85%
controls:0.59%
cases:1.21%
controls:0.11%
cases:7.73%
controls:0.64%
cases:15.31%
controls:1.97%
cases:30.02%
controls:5.52%
106
233
886
9680
118
155
874
9758
58
58
934
9855
12
11
980
9902
75
63
895
9798
130
182
719
9048
130
350
303
5993
fludrocortisone; oral
H02AA02 [21602726]
3.8e+00
3.7e+00
—
—
—
3.8e+00
3.9e+00
cases:2.92%
controls:0.07%
cases:2.82%
controls:0.07%
—
—
—
—
—
—
cases:3.65%
controls:0.09%
cases:6.70%
controls:0.14%
29
7
963
9906
28
7
964
9906
—
—
—
31
8
818
9222
29
9
404
6334
Supine thorax X-ray examination
GD1QA [2001303648]
1.9e+00
2.3e+00
3.9e+00
1.0e+50
2.5e+00
2.4e+00
2.1e+00
cases:11.29%
controls:1.86%
cases:8.27%
controls:0.87%
cases:4.64%
controls:0.10%
cases:2.32%
controls:0.00%
cases:1.65%
controls:0.13%
cases:11.66%
controls:1.18%
cases:28.41%
controls:4.81%
112
184
880
9729
82
86
910
9827
46
10
946
9903
23
0
969
9913
16
13
954
9848
99
109
750
9121
123
305
310
6038
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
2.8e+00
2.6e+00
2.1e+00
—
2.8e+00
2.2e+00
2.6e+00
cases:4.54%
controls:0.29%
cases:3.53%
controls:0.28%
cases:1.01%
controls:0.12%
—
—
cases:1.34%
controls:0.08%
cases:2.47%
controls:0.27%
cases:3.93%
controls:0.32%
45
29
947
9884
35
28
957
9885
10
12
982
9901
—
13
8
957
9853
21
25
828
9205
17
20
416
6323
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
2.8e+00
2.6e+00
2.1e+00
—
2.8e+00
2.2e+00
2.6e+00
cases:4.54%
controls:0.29%
cases:3.53%
controls:0.28%
cases:1.01%
controls:0.12%
—
—
cases:1.34%
controls:0.08%
cases:2.47%
controls:0.27%
cases:3.93%
controls:0.32%
45
29
947
9884
35
28
957
9885
10
12
982
9901
—
13
8
957
9853
21
25
828
9205
17
20
416
6323
duloxetine; oral
N06AX21 [21604749]
2.2e+00
2.4e+00
2.7e+00
—
2.8e+00
2.6e+00
2.2e+00
cases:3.93%
controls:0.43%
cases:2.82%
controls:0.26%
cases:1.01%
controls:0.07%
—
—
cases:1.65%
controls:0.10%
cases:3.42%
controls:0.26%
cases:5.08%
controls:0.60%
39
43
953
9870
28
26
964
9887
10
7
982
9906
—
16
10
954
9851
29
24
820
9206
22
38
411
6305
Malaise and fatigue
R53 [45553741]
2.1e+00
2.4e+00
3.2e+00
—
2.8e+00
2.7e+00
1.6e+00
cases:14.01%
controls:2.01%
cases:9.58%
controls:0.98%
cases:3.63%
controls:0.15%
—
—
cases:2.06%
controls:0.12%
cases:12.72%
controls:1.02%
cases:19.86%
controls:4.79%
139
199
853
9714
95
97
897
9816
36
15
956
9898
—
20
12
950
9849
108
94
741
9136
86
304
347
6039
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
2.2e+00
2.3e+00
3.0e+00
—
3.2e+00
2.5e+00
1.2e+00
cases:7.26%
controls:0.88%
cases:4.74%
controls:0.49%
cases:1.21%
controls:0.06%
—
—
cases:1.44%
controls:0.06%
cases:5.42%
controls:0.48%
cases:7.16%
controls:2.24%
72
87
920
9826
47
49
945
9864
12
6
980
9907
—
14
6
956
9855
46
44
803
9186
31
142
402
6201
Sleep apnoea
G47.3 [45562094]
3.7e+00
3.7e+00
—
1.0e+50
—
3.7e+00
3.0e+00
cases:6.85%
controls:0.18%
cases:4.13%
controls:0.11%
—
—
cases:1.92%
controls:0.00%
—
—
cases:3.89%
controls:0.10%
cases:5.31%
controls:0.27%
68
18
924
9895
41
11
951
9902
—
19
0
973
9913
—
33
9
816
9221
23
17
410
6326
Emergency Medicine
93 [38004510]
8.1e-01
1.3e+00
2.3e+00
5.3e+00
1.9e+00
1.5e+00
7.0e-01
cases:31.45%
controls:16.94%
cases:24.19%
controls:8.31%
cases:11.79%
controls:1.27%
cases:10.38%
controls:0.06%
cases:7.73%
controls:1.29%
cases:29.92%
controls:8.56%
cases:42.49%
controls:26.82%
312
1679
680
8234
240
824
752
9089
117
126
875
9787
103
6
889
9907
75
127
895
9734
254
790
595
8440
184
1701
249
4642
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.6e+00
2.3e+00
2.8e+00
—
2.7e+00
2.3e+00
2.0e+00
cases:15.83%
controls:3.83%
cases:12.20%
controls:1.34%
cases:3.83%
controls:0.24%
—
—
cases:3.40%
controls:0.24%
cases:13.66%
controls:1.51%
cases:32.33%
controls:6.15%
157
380
835
9533
121
133
871
9780
38
24
954
9889
—
33
24
937
9837
116
139
733
9091
140
390
293
5953
Memory disturbance
P20 [2002000816]
2.2e+00
2.7e+00
3.0e+00
—
2.8e+00
1.7e+00
1.3e+00
cases:11.59%
controls:1.41%
cases:7.66%
controls:0.58%
cases:1.92%
controls:0.10%
—
—
cases:1.65%
controls:0.10%
cases:4.24%
controls:0.83%
cases:9.24%
controls:2.68%
115
140
877
9773
76
57
916
9856
19
10
973
9903
—
16
10
954
9851
36
77
813
9153
40
170
393
6173
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
2.1e+00
2.8e+00
—
—
3.9e+00
3.1e+00
1.8e+00
cases:6.15%
controls:0.83%
cases:3.73%
controls:0.24%
—
—
—
—
cases:2.89%
controls:0.06%
cases:4.00%
controls:0.20%
cases:5.77%
controls:1.02%
61
82
931
9831
37
24
955
9889
—
—
28
6
942
9855
34
18
815
9212
25
65
408
6278
melatonin; oral
N05CH01 [21604659]
1.9e+00
2.0e+00
2.4e+00
—
2.6e+00
2.5e+00
2.0e+00
cases:9.68%
controls:1.54%
cases:7.46%
controls:1.08%
cases:4.23%
controls:0.38%
—
—
cases:4.74%
controls:0.37%
cases:12.84%
controls:1.21%
cases:18.01%
controls:2.85%
96
153
896
9760
74
107
918
9806
42
38
950
9875
—
46
36
924
9825
109
112
740
9118
78
181
355
6162
Counselling and guidance related to physical exercise
SPAT1305 [2001700406]
1.0e+00
2.5e+00
3.2e+00
—
2.6e+00
2.3e+00
1.7e+00
cases:3.63%
controls:1.30%
cases:4.33%
controls:0.35%
cases:1.51%
controls:0.06%
—
—
cases:1.24%
controls:0.09%
cases:3.89%
controls:0.42%
cases:6.93%
controls:1.34%
36
129
956
9784
43
35
949
9878
15
6
977
9907
—
12
9
958
9852
33
39
816
9191
30
85
403
6258
Orthostatic hypotension
I95.1 [45605872]
3.2e+00
3.4e+00
—
1.0e+50
1.0e+50
4.1e+00
2.6e+00
cases:5.24%
controls:0.23%
cases:4.74%
controls:0.17%
—
—
cases:3.23%
controls:0.00%
cases:1.65%
controls:0.00%
cases:6.71%
controls:0.12%
cases:8.08%
controls:0.66%
52
23
940
9890
47
17
945
9896
—
32
0
960
9913
16
0
954
9861
57
11
792
9219
35
42
398
6301
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
8.1e-01
1.3e+00
1.9e+00
4.6e+00
2.1e+00
1.4e+00
1.0e+00
cases:37.50%
controls:21.06%
cases:28.83%
controls:9.72%
cases:10.08%
controls:1.58%
cases:5.44%
controls:0.06%
cases:11.96%
controls:1.59%
cases:31.80%
controls:9.93%
cases:50.58%
controls:27.26%
372
2088
620
7825
286
964
706
8949
100
157
892
9756
54
6
938
9907
116
157
854
9704
270
917
579
8313
219
1729
214
4614
General Practice
1 [38004446]
1.5e+00
2.1e+00
2.6e+00
—
2.8e+00
2.3e+00
1.9e+00
cases:43.25%
controls:14.85%
cases:34.58%
controls:6.05%
cases:12.40%
controls:1.06%
—
—
cases:14.54%
controls:1.04%
cases:44.76%
controls:7.62%
cases:66.74%
controls:23.32%
429
1472
563
8441
343
600
649
9313
123
105
869
9808
—
141
103
829
9758
380
703
469
8527
289
1479
144
4864
citalopram; oral, parenteral
N06AB04 [21604712]
2.3e+00
2.2e+00
2.6e+00
—
1.8e+00
2.1e+00
2.0e+00
cases:8.37%
controls:0.92%
cases:4.94%
controls:0.58%
cases:1.81%
controls:0.14%
—
—
cases:1.24%
controls:0.20%
cases:4.48%
controls:0.59%
cases:5.77%
controls:0.82%
83
91
909
9822
49
57
943
9856
18
14
974
9899
—
12
20
958
9841
38
54
811
9176
25
52
408
6291
Limited function/disability (L)
L28 [2002000647]
1.8e+00
2.3e+00
2.2e+00
—
2.5e+00
2.4e+00
1.5e+00
cases:13.71%
controls:2.44%
cases:11.49%
controls:1.31%
cases:3.23%
controls:0.36%
—
—
cases:4.02%
controls:0.34%
cases:14.02%
controls:1.44%
cases:20.55%
controls:5.68%
136
242
856
9671
114
130
878
9783
32
36
960
9877
—
39
34
931
9827
119
133
730
9097
89
360
344
5983
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
7.8e-01
2.2e+00
3.0e+00
—
2.9e+00
2.3e+00
1.5e+00
cases:3.63%
controls:1.70%
cases:4.54%
controls:0.53%
cases:3.63%
controls:0.18%
—
—
cases:3.40%
controls:0.20%
cases:5.65%
controls:0.59%
cases:9.70%
controls:2.30%
36
169
956
9744
45
53
947
9860
36
18
956
9895
—
33
20
937
9841
48
54
801
9176
42
146
391
6197
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
1.4e+00
2.0e+00
2.5e+00
—
3.2e+00
2.1e+00
1.4e+00
cases:21.57%
controls:6.48%
cases:12.60%
controls:1.94%
cases:4.13%
controls:0.35%
—
—
cases:7.32%
controls:0.31%
cases:13.19%
controls:1.77%
cases:20.79%
controls:6.24%
214
642
778
9271
125
192
867
9721
41
35
951
9878
—
71
31
899
9830
112
163
737
9067
90
396
343
5947
Provision of support and information to patient’s family members
SPAT1245 [2001700346]
2.8e+00
2.5e+00
—
—
2.7e+00
2.8e+00
1.7e+00
cases:3.02%
controls:0.18%
cases:2.62%
controls:0.21%
—
—
—
—
cases:0.93%
controls:0.06%
cases:3.30%
controls:0.21%
cases:4.85%
controls:0.96%
30
18
962
9895
26
21
966
9892
—
—
9
6
961
9855
28
19
821
9211
21
61
412
6282
Speech therapy
R4130 [2001310235]
3.2e+00
3.0e+00
—
—
1.0e+50
3.0e+00
3.3e+00
cases:1.92%
controls:0.08%
cases:1.01%
controls:0.05%
—
—
—
—
cases:0.52%
controls:0.00%
cases:1.30%
controls:0.07%
cases:3.00%
controls:0.11%
19
8
973
9905
10
5
982
9908
—
—
5
0
965
9861
11
6
838
9224
13
7
420
6336
Weakness/tiredness general
A04 [2002000145]
1.5e+00
1.9e+00
2.7e+00
—
2.7e+00
2.1e+00
1.6e+00
cases:6.25%
controls:1.53%
cases:4.44%
controls:0.70%
cases:2.42%
controls:0.16%
—
—
cases:1.86%
controls:0.13%
cases:6.36%
controls:0.82%
cases:12.70%
controls:2.79%
62
152
930
9761
44
69
948
9844
24
16
968
9897
—
18
13
952
9848
54
76
795
9154
55
177
378
6166
Assessment of need for aid
SPAT1229 [2001700330]
2.2e+00
2.5e+00
2.9e+00
—
—
2.7e+00
2.0e+00
cases:6.96%
controls:0.84%
cases:3.73%
controls:0.30%
cases:0.91%
controls:0.05%
—
—
—
—
cases:3.89%
controls:0.26%
cases:7.85%
controls:1.15%
69
83
923
9830
37
30
955
9883
9
5
983
9908
—
—
33
24
816
9206
34
73
399
6270
mirabegron; oral
G04BD12 [43534790]
2.0e+00
2.1e+00
2.3e+00
—
2.3e+00
2.0e+00
1.6e+00
cases:17.04%
controls:2.71%
cases:14.01%
controls:1.91%
cases:5.85%
controls:0.65%
—
—
cases:6.91%
controls:0.76%
cases:14.49%
controls:2.33%
cases:16.40%
controls:3.99%
169
269
823
9644
139
189
853
9724
58
64
934
9849
—
67
75
903
9786
123
215
726
9015
71
253
362
6090
lactulose; oral
A06AD11 [21600571]
1.7e+00
2.0e+00
2.1e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:11.19%
controls:2.22%
cases:8.67%
controls:1.28%
cases:3.23%
controls:0.41%
—
—
cases:2.68%
controls:0.29%
cases:10.84%
controls:1.44%
cases:19.17%
controls:3.15%
111
220
881
9693
86
127
906
9786
32
41
960
9872
—
26
29
944
9832
92
133
757
9097
83
200
350
6143
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
2.5e+00
3.3e+00
—
—
—
3.4e+00
2.6e+00
cases:2.12%
controls:0.18%
cases:1.41%
controls:0.05%
—
—
—
—
—
—
cases:2.59%
controls:0.09%
cases:2.77%
controls:0.22%
21
18
971
9895
14
5
978
9908
—
—
—
22
8
827
9222
12
14
421
6329
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.1e+00
1.6e+00
3.1e+00
1.0e+50
2.9e+00
1.8e+00
1.3e+00
cases:15.42%
controls:5.51%
cases:9.68%
controls:2.08%
cases:3.53%
controls:0.17%
cases:2.42%
controls:0.00%
cases:2.99%
controls:0.16%
cases:10.48%
controls:1.95%
cases:21.25%
controls:7.09%
153
546
839
9367
96
206
896
9707
35
17
957
9896
24
0
968
9913
29
16
941
9845
89
180
760
9050
92
450
341
5893
No procedures
SPAT1301 [2001700402]
8.9e-01
1.5e+00
2.2e+00
2.9e+00
2.3e+00
1.4e+00
5.8e-01
cases:16.33%
controls:7.43%
cases:10.48%
controls:2.52%
cases:5.14%
controls:0.58%
cases:2.32%
controls:0.13%
cases:5.05%
controls:0.54%
cases:10.25%
controls:2.80%
cases:15.24%
controls:9.16%
162
737
830
9176
104
250
888
9663
51
57
941
9856
23
13
969
9900
49
53
921
9808
87
258
762
8972
66
581
367
5762
mirtazapine; oral
N06AX11 [21604740]
1.9e+00
1.9e+00
2.1e+00
—
2.2e+00
1.9e+00
1.7e+00
cases:17.94%
controls:3.19%
cases:13.10%
controls:2.12%
cases:5.44%
controls:0.72%
—
—
cases:5.15%
controls:0.63%
cases:14.37%
controls:2.38%
cases:23.33%
controls:5.19%
178
316
814
9597
130
210
862
9703
54
71
938
9842
—
50
62
920
9799
122
220
727
9010
101
329
332
6014
Incontinence urine
U04 [2002001139]
1.7e+00
2.3e+00
—
—
2.8e+00
2.9e+00
1.9e+00
cases:3.13%
controls:0.59%
cases:2.82%
controls:0.28%
—
—
—
—
cases:0.82%
controls:0.05%
cases:4.48%
controls:0.25%
cases:6.93%
controls:1.10%
31
58
961
9855
28
28
964
9885
—
—
8
5
962
9856
38
23
811
9207
30
70
403
6273
vortioxetine; oral
N06AX26 [44819158]
2.7e+00
1.7e+00
—
—
2.7e+00
3.0e+00
3.3e+00
cases:1.31%
controls:0.09%
cases:0.60%
controls:0.11%
—
—
—
—
cases:0.72%
controls:0.05%
cases:1.65%
controls:0.09%
cases:3.23%
controls:0.13%
13
9
979
9904
6
11
986
9902
—
—
7
5
963
9856
14
8
835
9222
14
8
419
6335
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
7.3e-01
1.1e+00
1.8e+00
4.2e+00
1.8e+00
1.2e+00
6.3e-01
cases:37.70%
controls:22.62%
cases:26.71%
controls:10.51%
cases:8.37%
controls:1.55%
cases:4.03%
controls:0.06%
cases:9.18%
controls:1.62%
cases:28.27%
controls:10.72%
cases:42.49%
controls:28.27%
374
2242
618
7671
265
1042
727
8871
83
154
909
9759
40
6
952
9907
89
160
881
9701
240
989
609
8241
184
1793
249
4550
Internal Medicine
11 [38004456]
7.8e-01
1.0e+00
1.7e+00
5.1e+00
1.0e+00
9.2e-01
9.0e-01
cases:42.34%
controls:25.15%
cases:24.29%
controls:10.38%
cases:9.58%
controls:1.86%
cases:10.18%
controls:0.07%
cases:5.26%
controls:1.93%
cases:23.44%
controls:10.92%
cases:45.03%
controls:25.02%
420
2493
572
7420
241
1029
751
8884
95
184
897
9729
101
7
891
9906
51
190
919
9671
199
1008
650
8222
195
1587
238
4756
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
1.7e+00
2.0e+00
1.7e+00
—
2.7e+00
1.9e+00
1.4e+00
cases:12.30%
controls:2.59%
cases:6.65%
controls:0.97%
cases:0.91%
controls:0.16%
—
—
cases:1.96%
controls:0.13%
cases:6.95%
controls:1.13%
cases:13.86%
controls:3.64%
122
257
870
9656
66
96
926
9817
9
16
983
9897
—
19
13
951
9848
59
104
790
9126
60
231
373
6112
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
7.0e-01
9.9e-01
1.9e+00
4.2e+00
1.7e+00
1.1e+00
7.3e-01
cases:28.93%
controls:16.86%
cases:18.35%
controls:7.74%
cases:6.65%
controls:1.02%
cases:5.04%
controls:0.08%
cases:4.64%
controls:0.89%
cases:20.49%
controls:7.63%
cases:37.88%
controls:22.67%
287
1671
705
8242
182
767
810
9146
66
101
926
9812
50
8
942
9905
45
88
925
9773
174
704
675
8526
164
1438
269
4905
Voluntary or Charitable Agency
251V00000X [38004202]
2.9e+00
2.6e+00
—
—
—
2.8e+00
2.8e+00
cases:3.83%
controls:0.21%
cases:2.22%
controls:0.16%
—
—
—
—
—
—
cases:3.18%
controls:0.20%
cases:9.24%
controls:0.65%
38
21
954
9892
22
16
970
9897
—
—
—
27
18
822
9212
40
41
393
6302
acetylsalicylic acid; oral
B01AC06 [21600991]
1.4e+00
1.7e+00
2.2e+00
—
2.3e+00
1.9e+00
1.6e+00
cases:10.18%
controls:2.75%
cases:8.37%
controls:1.61%
cases:4.64%
controls:0.54%
—
—
cases:4.85%
controls:0.51%
cases:9.89%
controls:1.59%
cases:16.63%
controls:3.99%
101
273
891
9640
83
160
909
9753
46
54
946
9859
—
47
50
923
9811
84
147
765
9083
72
253
361
6090
Neurosurgery
14 [38004459]
2.0e+00
2.1e+00
2.8e+00
1.0e+50
—
2.1e+00
2.0e+00
cases:7.76%
controls:1.12%
cases:3.02%
controls:0.36%
cases:0.81%
controls:0.05%
cases:0.50%
controls:0.00%
—
—
cases:3.30%
controls:0.43%
cases:7.16%
controls:1.01%
77
111
915
9802
30
36
962
9877
8
5
984
9908
5
0
987
9913
—
28
40
821
9190
31
64
402
6279
Concussion
S06.0 [45582805]
3.8e+00
—
—
—
1.0e+50
3.2e+00
4.0e+00
cases:2.22%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.00%
cases:1.77%
controls:0.08%
cases:8.31%
controls:0.17%
22
5
970
9908
—
—
—
5
0
965
9861
15
7
834
9223
36
11
397
6332
cyanocobalamin; nasal, oral, parenteral
B03BA01 [21601121]
1.5e+00
1.7e+00
1.9e+00
—
2.2e+00
1.9e+00
1.7e+00
cases:2.22%
controls:0.51%
cases:1.71%
controls:0.31%
cases:0.91%
controls:0.14%
—
—
cases:1.03%
controls:0.11%
cases:2.59%
controls:0.39%
cases:3.93%
controls:0.74%
22
51
970
9862
17
31
975
9882
9
14
983
9899
—
10
11
960
9850
22
36
827
9194
17
47
416
6296
oxazepam; oral
N05BA04 [21604569]
1.5e+00
1.5e+00
2.1e+00
—
1.9e+00
1.9e+00
2.0e+00
cases:11.19%
controls:2.73%
cases:6.55%
controls:1.55%
cases:2.52%
controls:0.32%
—
—
cases:2.89%
controls:0.44%
cases:10.72%
controls:1.80%
cases:19.40%
controls:3.26%
111
271
881
9642
65
154
927
9759
25
32
967
9881
—
28
43
942
9818
91
166
758
9064
84
207
349
6136
Acute tubulo-interstitial nephritis
N10 [45543856]
1.2e+00
1.7e+00
2.4e+00
—
2.0e+00
2.0e+00
1.6e+00
cases:5.95%
controls:1.90%
cases:3.93%
controls:0.72%
cases:1.31%
controls:0.12%
—
—
cases:0.72%
controls:0.10%
cases:5.18%
controls:0.75%
cases:13.16%
controls:3.11%
59
188
933
9725
39
71
953
9842
13
12
979
9901
—
7
10
963
9851
44
69
805
9161
57
197
376
6146
Open wound of eyelid and periocular area
S01.1 [45602056]
2.3e+00
2.6e+00
—
—
—
2.6e+00
3.0e+00
cases:1.92%
controls:0.19%
cases:0.71%
controls:0.05%
—
—
—
—
—
—
cases:0.71%
controls:0.05%
cases:2.08%
controls:0.11%
19
19
973
9894
7
5
985
9908
—
—
—
6
5
843
9225
9
7
424
6336
Geriatric Medicine
38 [38004478]
2.0e+00
3.1e+00
—
1.0e+50
—
3.2e+00
2.1e+00
cases:4.13%
controls:0.55%
cases:4.03%
controls:0.18%
—
—
cases:6.35%
controls:0.00%
—
—
cases:7.66%
controls:0.34%
cases:9.47%
controls:1.29%
41
55
951
9858
40
18
952
9895
—
63
0
929
9913
—
65
31
784
9199
41
82
392
6261
Treatment of a patient needing special arrangements
WYA30 [2001310874]
2.1e+00
2.4e+00
—
—
—
2.8e+00
3.1e+00
cases:3.63%
controls:0.46%
cases:2.22%
controls:0.20%
—
—
—
—
—
—
cases:3.30%
controls:0.21%
cases:12.01%
controls:0.61%
36
46
956
9867
22
20
970
9893
—
—
—
28
19
821
9211
52
39
381
6304
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
9.8e-01
1.7e+00
2.7e+00
—
2.2e+00
1.7e+00
1.0e+00
cases:6.55%
controls:2.56%
cases:4.44%
controls:0.81%
cases:3.23%
controls:0.23%
—
—
cases:2.47%
controls:0.27%
cases:5.89%
controls:1.08%
cases:8.55%
controls:3.26%
65
254
927
9659
44
80
948
9833
32
23
960
9890
—
24
27
946
9834
50
100
799
9130
37
207
396
6136
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.7e-01
1.1e+00
1.5e+00
3.4e+00
2.0e+00
8.8e-01
5.9e-01
cases:23.79%
controls:12.61%
cases:18.04%
controls:6.63%
cases:4.54%
controls:1.01%
cases:1.81%
controls:0.06%
cases:7.63%
controls:1.11%
cases:15.08%
controls:6.85%
cases:27.71%
controls:17.59%
236
1250
756
8663
179
657
813
9256
45
100
947
9813
18
6
974
9907
74
109
896
9752
128
632
721
8598
120
1116
313
5227
magnesium hydroxide; oral
A02AA04 [21600052]
6.1e-01
2.3e+00
2.4e+00
—
2.2e+00
1.7e+00
1.7e+00
cases:0.91%
controls:0.49%
cases:1.61%
controls:0.17%
cases:0.91%
controls:0.08%
—
—
cases:0.82%
controls:0.09%
cases:1.88%
controls:0.34%
cases:3.93%
controls:0.76%
9
49
983
9864
16
17
976
9896
9
8
983
9905
—
8
9
962
9852
16
31
833
9199
17
48
416
6295
magnesium hydroxide; oral
G04BX01 [21602658]
6.1e-01
2.3e+00
2.4e+00
—
2.2e+00
1.7e+00
1.7e+00
cases:0.91%
controls:0.49%
cases:1.61%
controls:0.17%
cases:0.91%
controls:0.08%
—
—
cases:0.82%
controls:0.09%
cases:1.88%
controls:0.34%
cases:3.93%
controls:0.76%
9
49
983
9864
16
17
976
9896
9
8
983
9905
—
8
9
962
9852
16
31
833
9199
17
48
416
6295
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
2.2e+00
2.4e+00
—
—
—
2.7e+00
3.0e+00
cases:2.92%
controls:0.32%
cases:2.32%
controls:0.21%
—
—
—
—
—
—
cases:4.00%
controls:0.28%
cases:10.39%
controls:0.60%
29
32
963
9881
23
21
969
9892
—
—
—
34
26
815
9204
45
38
388
6305
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.2e-01
8.4e-01
1.5e+00
3.9e+00
1.9e+00
1.1e+00
5.6e-01
cases:48.39%
controls:38.20%
cases:41.03%
controls:23.16%
cases:18.85%
controls:4.92%
cases:16.03%
controls:0.38%
cases:26.80%
controls:5.06%
cases:47.11%
controls:22.54%
cases:63.05%
controls:49.24%
480
3787
512
6126
407
2296
585
7617
187
488
805
9425
159
38
833
9875
260
499
710
9362
400
2080
449
7150
273
3123
160
3220
Fracture of neck of femur
S72.0 [45593656]
1.8e+00
2.0e+00
—
1.0e+50
2.7e+00
1.7e+00
2.1e+00
cases:2.52%
controls:0.44%
cases:2.22%
controls:0.30%
—
—
cases:1.31%
controls:0.00%
cases:0.72%
controls:0.05%
cases:1.77%
controls:0.31%
cases:8.31%
controls:1.10%
25
44
967
9869
22
30
970
9883
—
13
0
979
9913
7
5
963
9856
15
29
834
9201
36
70
397
6273
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.6e+00
1.5e+00
1.9e+00
—
1.5e+00
1.9e+00
1.7e+00
cases:6.85%
controls:1.45%
cases:4.03%
controls:0.96%
cases:2.22%
controls:0.34%
—
—
cases:1.96%
controls:0.44%
cases:7.89%
controls:1.31%
cases:16.86%
controls:3.55%
68
144
924
9769
40
95
952
9818
22
34
970
9879
—
19
43
951
9818
67
121
782
9109
73
225
360
6118
Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]
2.5e-01
1.4e+00
2.5e+00
2.2e+00
2.3e+00
1.6e+00
6.1e-01
cases:2.72%
controls:2.13%
cases:2.72%
controls:0.69%
cases:2.02%
controls:0.16%
cases:0.60%
controls:0.07%
cases:2.06%
controls:0.20%
cases:3.18%
controls:0.66%
cases:5.31%
controls:2.96%
27
211
965
9702
27
68
965
9845
20
16
972
9897
6
7
986
9906
20
20
950
9841
27
61
822
9169
23
188
410
6155
gabapentin; oral
N02BF01 [955005]
1.6e+00
1.7e+00
2.1e+00
—
2.0e+00
1.5e+00
1.0e+00
cases:9.17%
controls:2.02%
cases:5.65%
controls:1.06%
cases:2.62%
controls:0.33%
—
—
cases:2.78%
controls:0.39%
cases:5.77%
controls:1.29%
cases:7.85%
controls:2.95%
91
200
901
9713
56
105
936
9808
26
33
966
9880
—
27
38
943
9823
49
119
800
9111
34
187
399
6156
Open wound of scalp
S01.0 [45592468]
2.0e+00
2.4e+00
—
—
—
3.3e+00
2.3e+00
cases:4.13%
controls:0.61%
cases:2.02%
controls:0.19%
—
—
—
—
—
—
cases:3.53%
controls:0.14%
cases:10.16%
controls:1.09%
41
60
951
9853
20
19
972
9894
—
—
—
30
13
819
9217
44
69
389
6274
Counselling and guidance related to ageing
SPAT1304 [2001700405]
9.2e-01
1.9e+00
2.2e+00
—
2.6e+00
1.3e+00
8.8e-01
cases:3.73%
controls:1.52%
cases:3.13%
controls:0.46%
cases:1.41%
controls:0.15%
—
—
cases:1.34%
controls:0.10%
cases:2.71%
controls:0.73%
cases:4.85%
controls:2.07%
37
151
955
9762
31
46
961
9867
14
15
978
9898
—
13
10
957
9851
23
67
826
9163
21
131
412
6212
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
8.6e-01
1.1e+00
1.6e+00
3.0e+00
1.9e+00
8.6e-01
4.8e-01
cases:28.33%
controls:14.34%
cases:21.27%
controls:8.11%
cases:5.95%
controls:1.29%
cases:1.81%
controls:0.09%
cases:8.97%
controls:1.42%
cases:16.96%
controls:7.97%
cases:30.25%
controls:21.19%
281
1422
711
8491
211
804
781
9109
59
128
933
9785
18
9
974
9904
87
140
883
9721
144
736
705
8494
131
1344
302
4999
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.0e+00
1.4e+00
2.3e+00
1.0e+50
2.3e+00
1.6e+00
1.2e+00
cases:6.85%
controls:2.59%
cases:5.24%
controls:1.39%
cases:1.92%
controls:0.20%
cases:1.01%
controls:0.00%
cases:1.65%
controls:0.16%
cases:8.24%
controls:1.81%
cases:16.86%
controls:5.98%
68
257
924
9656
52
138
940
9775
19
20
973
9893
10
0
982
9913
16
16
954
9845
70
167
779
9063
73
379
360
5964
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
9.0e-01
1.3e+00
2.2e+00
—
2.1e+00
1.8e+00
1.3e+00
cases:5.85%
controls:2.47%
cases:4.84%
controls:1.33%
cases:3.63%
controls:0.42%
—
—
cases:3.51%
controls:0.43%
cases:7.54%
controls:1.32%
cases:12.70%
controls:3.67%
58
245
934
9668
48
132
944
9781
36
42
956
9871
—
34
42
936
9819
64
122
785
9108
55
233
378
6110
Bacteria identified in Urine by Culture
630-4 [3026008]
1.0e+00
1.5e+00
2.1e+00
1.0e+50
2.0e+00
1.7e+00
1.1e+00
cases:19.66%
controls:8.10%
cases:15.22%
controls:3.75%
cases:4.23%
controls:0.51%
cases:2.32%
controls:0.00%
cases:4.33%
controls:0.64%
cases:19.32%
controls:4.19%
cases:31.18%
controls:12.75%
195
803
797
9110
151
372
841
9541
42
51
950
9862
23
0
969
9913
42
63
928
9798
164
387
685
8843
135
809
298
5534
Emergency Room and Inpatient Visit
ERIP [262]
1.1e+00
1.6e+00
2.4e+00
—
1.8e+00
1.6e+00
9.5e-01
cases:16.73%
controls:6.23%
cases:14.72%
controls:3.48%
cases:6.35%
controls:0.61%
—
—
cases:3.51%
controls:0.60%
cases:18.37%
controls:4.26%
cases:30.02%
controls:14.22%
166
618
826
9295
146
345
846
9568
63
60
929
9853
—
34
59
936
9802
156
393
693
8837
130
902
303
5441
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.2e+00
1.6e+00
2.2e+00
—
2.7e+00
1.0e+00
6.7e-01
cases:13.51%
controls:4.34%
cases:12.50%
controls:2.73%
cases:3.13%
controls:0.37%
—
—
cases:4.64%
controls:0.32%
cases:9.19%
controls:3.52%
cases:19.63%
controls:11.08%
134
430
858
9483
124
271
868
9642
31
37
961
9876
—
45
32
925
9829
78
325
771
8905
85
703
348
5640
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
3.0e+00
3.2e+00
—
—
1.0e+50
—
3.2e+00
cases:2.02%
controls:0.10%
cases:1.41%
controls:0.06%
—
—
—
—
cases:0.62%
controls:0.00%
—
—
cases:4.85%
controls:0.20%
20
10
972
9903
14
6
978
9907
—
—
6
0
964
9861
—
21
13
412
6330
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.6e+00
1.8e+00
—
1.9e+00
1.6e+00
1.3e+00
cases:8.17%
controls:2.63%
cases:5.44%
controls:1.20%
cases:2.32%
controls:0.38%
—
—
cases:2.37%
controls:0.34%
cases:5.77%
controls:1.25%
cases:10.62%
controls:3.17%
81
261
911
9652
54
119
938
9794
23
38
969
9875
—
23
34
947
9827
49
115
800
9115
46
201
387
6142
sodium picosulfate; oral
A06AB08 [21600545]
1.7e+00
2.6e+00
—
—
—
2.9e+00
2.1e+00
cases:1.21%
controls:0.23%
cases:0.71%
controls:0.05%
—
—
—
—
—
—
cases:1.41%
controls:0.08%
cases:4.16%
controls:0.54%
12
23
980
9890
7
5
985
9908
—
—
—
12
7
837
9223
18
34
415
6309
bupropion; oral
N06AX12 [21604741]
1.9e+00
2.2e+00
—
—
—
2.4e+00
2.9e+00
cases:1.01%
controls:0.15%
cases:0.60%
controls:0.07%
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:1.62%
controls:0.09%
10
15
982
9898
6
7
986
9906
—
—
—
6
6
843
9224
7
6
426
6337
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.2e+00
1.3e+00
1.8e+00
1.0e+50
2.2e+00
1.6e+00
1.2e+00
cases:5.14%
controls:1.61%
cases:3.53%
controls:1.01%
cases:1.01%
controls:0.16%
cases:0.81%
controls:0.00%
cases:1.24%
controls:0.14%
cases:6.36%
controls:1.39%
cases:13.63%
controls:4.54%
51
160
941
9753
35
100
957
9813
10
16
982
9897
8
0
984
9913
12
14
958
9847
54
128
795
9102
59
288
374
6055
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.2e+00
1.3e+00
1.9e+00
1.0e+50
2.2e+00
1.5e+00
1.1e+00
cases:5.14%
controls:1.66%
cases:3.43%
controls:0.96%
cases:1.01%
controls:0.15%
cases:0.71%
controls:0.00%
cases:1.13%
controls:0.13%
cases:5.77%
controls:1.35%
cases:11.78%
controls:4.29%
51
165
941
9748
34
95
958
9818
10
15
982
9898
7
0
985
9913
11
13
959
9848
49
125
800
9105
51
272
382
6071
sertraline; oral
N06AB06 [21604714]
2.0e+00
2.2e+00
—
—
—
2.8e+00
2.0e+00
cases:1.71%
controls:0.24%
cases:1.21%
controls:0.13%
—
—
—
—
—
—
cases:1.65%
controls:0.10%
cases:2.54%
controls:0.35%
17
24
975
9889
12
13
980
9900
—
—
—
14
9
835
9221
11
22
422
6321
Occupational Medicine Clinic/Center
261QX0100X [38004267]
3.1e+00
—
—
—
1.0e+50
3.5e+00
2.5e+00
cases:1.51%
controls:0.07%
—
—
—
—
—
—
cases:1.75%
controls:0.00%
cases:1.77%
controls:0.05%
cases:3.46%
controls:0.30%
15
7
977
9906
—
—
—
17
0
953
9861
15
5
834
9225
15
19
418
6324
Volume depletion
E86 [45581386]
2.8e+00
2.3e+00
—
—
—
1.9e+00
2.0e+00
cases:1.41%
controls:0.09%
cases:0.60%
controls:0.06%
—
—
—
—
—
—
cases:1.06%
controls:0.16%
cases:2.77%
controls:0.38%
14
9
978
9904
6
6
986
9907
—
—
—
9
15
840
9215
12
24
421
6319
Psychiatry
26 [38004469]
4.8e+00
—
—
1.0e+50
—
—
4.1e+00
cases:6.85%
controls:0.06%
—
—
—
—
cases:2.12%
controls:0.00%
—
—
—
—
cases:7.16%
controls:0.13%
68
6
924
9907
—
—
21
0
971
9913
—
—
31
8
402
6335
Emergency Room Visit
ER [9203]
9.8e-01
1.3e+00
2.4e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:55.04%
controls:31.51%
cases:32.86%
controls:11.27%
cases:15.12%
controls:1.63%
—
—
cases:7.73%
controls:1.61%
cases:32.39%
controls:11.89%
cases:58.89%
controls:31.59%
546
3124
446
6789
326
1117
666
8796
150
162
842
9751
—
75
159
895
9702
275
1097
574
8133
255
2004
178
4339
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
1.3e+00
1.7e+00
1.5e+00
—
3.0e+00
1.5e+00
1.2e+00
cases:16.83%
controls:5.38%
cases:7.76%
controls:1.47%
cases:0.60%
controls:0.13%
—
—
cases:2.58%
controls:0.13%
cases:5.65%
controls:1.31%
cases:14.55%
controls:4.81%
167
533
825
9380
77
146
915
9767
6
13
986
9900
—
25
13
945
9848
48
121
801
9109
63
305
370
6038
Microorganisms panel - Urine sediment
58435-9 [40761536]
8.3e-01
1.1e+00
2.3e+00
1.0e+50
2.1e+00
1.6e+00
8.1e-01
cases:5.85%
controls:2.63%
cases:3.23%
controls:1.07%
cases:1.51%
controls:0.15%
cases:0.81%
controls:0.00%
cases:1.65%
controls:0.21%
cases:3.89%
controls:0.85%
cases:6.47%
controls:2.98%
58
261
934
9652
32
106
960
9807
15
15
977
9898
8
0
984
9913
16
21
954
9840
33
78
816
9152
28
189
405
6154
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
6.8e-01
9.6e-01
2.1e+00
—
2.5e+00
1.6e+00
8.4e-01
cases:5.54%
controls:2.90%
cases:3.53%
controls:1.38%
cases:1.41%
controls:0.18%
—
—
cases:2.06%
controls:0.17%
cases:5.54%
controls:1.12%
cases:8.78%
controls:4.00%
55
287
937
9626
35
137
957
9776
14
18
978
9895
—
20
17
950
9844
47
103
802
9127
38
254
395
6089
Cervical spine CT examination
NA1AD [2001306982]
1.7e+00
2.3e+00
—
—
—
2.2e+00
2.5e+00
cases:1.21%
controls:0.23%
cases:0.81%
controls:0.08%
—
—
—
—
—
—
cases:1.06%
controls:0.12%
cases:3.00%
controls:0.25%
12
23
980
9890
8
8
984
9905
—
—
—
9
11
840
9219
13
16
420
6327
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
2.9e+00
—
—
—
1.0e+50
2.8e+00
2.9e+00
cases:4.74%
controls:0.27%
—
—
—
—
—
—
cases:0.62%
controls:0.00%
cases:1.30%
controls:0.08%
cases:4.16%
controls:0.24%
47
27
945
9886
—
—
—
6
0
964
9861
11
7
838
9223
18
15
415
6328
Bacteria identified in Blood by Culture
600-7 [3023368]
8.5e-01
1.0e+00
2.1e+00
—
2.2e+00
1.4e+00
9.8e-01
cases:13.91%
controls:6.46%
cases:7.66%
controls:2.86%
cases:3.13%
controls:0.39%
—
—
cases:2.99%
controls:0.33%
cases:11.78%
controls:3.15%
cases:25.17%
controls:11.19%
138
640
854
9273
76
284
916
9629
31
39
961
9874
—
29
33
941
9828
100
291
749
8939
109
710
324
5633
Urinary tract infection, site not specified
N39.0 [45548665]
1.4e+00
1.7e+00
2.2e+00
1.0e+50
1.3e+00
2.0e+00
1.3e+00
cases:7.06%
controls:1.91%
cases:4.84%
controls:0.89%
cases:1.31%
controls:0.15%
cases:0.71%
controls:0.00%
cases:0.52%
controls:0.14%
cases:5.54%
controls:0.79%
cases:12.93%
controls:3.91%
70
189
922
9724
48
88
944
9825
13
15
979
9898
7
0
985
9913
5
14
965
9847
47
73
802
9157
56
248
377
6095
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
NFB20 [2001307920]
2.2e+00
2.3e+00
1.0e+50
—
—
1.8e+00
2.2e+00
cases:1.71%
controls:0.20%
cases:1.21%
controls:0.12%
cases:0.60%
controls:0.00%
—
—
—
—
cases:0.94%
controls:0.16%
cases:5.54%
controls:0.63%
17
20
975
9893
12
12
980
9901
6
0
986
9913
—
—
8
15
841
9215
24
40
409
6303
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6.8e-01
1.1e+00
2.4e+00
—
2.0e+00
1.3e+00
8.1e-01
cases:19.15%
controls:10.74%
cases:12.50%
controls:4.52%
cases:5.75%
controls:0.54%
—
—
cases:4.23%
controls:0.61%
cases:15.43%
controls:4.68%
cases:30.02%
controls:16.06%
190
1065
802
8848
124
448
868
9465
57
54
935
9859
—
41
60
929
9801
131
432
718
8798
130
1019
303
5324
Contusion of hip
S70.0 [45574306]
2.0e+00
2.2e+00
—
—
—
2.2e+00
1.9e+00
cases:1.92%
controls:0.26%
cases:1.21%
controls:0.13%
—
—
—
—
—
—
cases:1.06%
controls:0.12%
cases:3.23%
controls:0.52%
19
26
973
9887
12
13
980
9900
—
—
—
9
11
840
9219
14
33
419
6310
Pneumonia, unspecified
J18.9 [45601123]
6.5e-01
1.1e+00
2.2e+00
1.0e+50
1.5e+00
1.3e+00
1.5e+00
cases:9.07%
controls:4.96%
cases:5.54%
controls:1.97%
cases:2.92%
controls:0.33%
cases:2.72%
controls:0.00%
cases:1.44%
controls:0.31%
cases:9.19%
controls:2.62%
cases:28.87%
controls:8.40%
90
492
902
9421
55
195
937
9718
29
33
963
9880
27
0
965
9913
14
31
956
9830
78
242
771
8988
125
533
308
5810
Other function in accordance with physical therapy nomenclature
SPAT1295 [2001700396]
1.9e+00
2.3e+00
—
—
—
2.2e+00
2.0e+00
cases:3.43%
controls:0.55%
cases:1.61%
controls:0.17%
—
—
—
—
—
—
cases:1.53%
controls:0.17%
cases:4.39%
controls:0.65%
34
55
958
9858
16
17
976
9896
—
—
—
13
16
836
9214
19
41
414
6302
Insertion of urinary catheter
SPAT1167 [2001700268]
1.3e+00
2.3e+00
—
—
—
2.6e+00
1.9e+00
cases:1.31%
controls:0.35%
cases:1.51%
controls:0.15%
—
—
—
—
—
—
cases:2.71%
controls:0.21%
cases:6.00%
controls:0.95%
13
35
979
9878
15
15
977
9898
—
—
—
23
19
826
9211
26
60
407
6283
dipyridamole; oral, parenteral
B01AC07 [21600992]
2.2e+00
2.0e+00
—
—
2.0e+00
1.7e+00
2.3e+00
cases:2.72%
controls:0.31%
cases:1.41%
controls:0.20%
—
—
—
—
cases:0.52%
controls:0.07%
cases:0.94%
controls:0.17%
cases:1.39%
controls:0.14%
27
31
965
9882
14
20
978
9893
—
—
5
7
965
9854
8
16
841
9214
6
9
427
6334
Outpatient Visit
OP [9202]
1.5e+00
1.0e+00
6.0e-01
3.7e+00
5.7e-01
6.9e-01
4.6e-01
cases:95.97%
controls:84.43%
cases:83.97%
controls:65.61%
cases:21.37%
controls:12.98%
cases:19.86%
controls:0.59%
cases:20.72%
controls:12.89%
cases:78.56%
controls:64.82%
cases:93.76%
controls:90.43%
952
8370
40
1543
833
6504
159
3409
212
1287
780
8626
197
58
795
9855
201
1271
769
8590
667
5983
182
3247
406
5736
27
607
CBC panel - Blood by Automated count
58410-2 [40761511]
3.2e-01
5.8e-01
1.3e+00
3.7e+00
1.6e+00
5.7e-01
2.1e-01
cases:51.71%
controls:43.84%
cases:41.33%
controls:28.22%
cases:16.94%
controls:5.21%
cases:11.49%
controls:0.33%
cases:22.27%
controls:5.26%
cases:40.28%
controls:27.68%
cases:58.20%
controls:52.92%
513
4346
479
5567
410
2797
582
7116
168
516
824
9397
114
33
878
9880
216
519
754
9342
342
2555
507
6675
252
3357
181
2986
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.9e-01
5.9e-01
1.3e+00
3.6e+00
1.7e+00
5.7e-01
6.3e-02
cases:57.46%
controls:50.27%
cases:53.83%
controls:39.35%
cases:22.48%
controls:7.31%
cases:15.73%
controls:0.48%
cases:30.21%
controls:7.51%
cases:54.42%
controls:40.39%
cases:67.21%
controls:65.80%
570
4983
422
4930
534
3901
458
6012
223
725
769
9188
156
48
836
9865
293
741
677
9120
462
3728
387
5502
291
4174
142
2169
Outpatient Hospital
22 [8756]
5.5e-01
8.8e-01
2.0e+00
—
2.5e+00
1.2e+00
8.6e-01
cases:37.40%
controls:25.67%
cases:16.23%
controls:7.45%
cases:6.05%
controls:0.83%
—
—
cases:10.41%
controls:0.92%
cases:20.14%
controls:7.30%
cases:36.03%
controls:19.28%
371
2545
621
7368
161
739
831
9174
60
82
932
9831
—
101
91
869
9770
171
674
678
8556
156
1223
277
5120
Unspecified fall
W19 [45756257]
1.6e+00
2.2e+00
—
1.0e+50
—
2.2e+00
2.0e+00
cases:3.53%
controls:0.73%
cases:2.22%
controls:0.25%
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.83%
controls:0.31%
cases:8.08%
controls:1.21%
35
72
957
9841
22
25
970
9888
—
5
0
987
9913
—
24
29
825
9201
35
77
398
6266
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.7e-01
5.7e-01
1.3e+00
3.6e+00
1.6e+00
5.4e-01
4.7e-02
cases:57.26%
controls:50.68%
cases:54.13%
controls:40.09%
cases:22.38%
controls:7.40%
cases:15.73%
controls:0.48%
cases:30.21%
controls:7.70%
cases:54.30%
controls:40.87%
cases:67.21%
controls:66.17%
568
5024
424
4889
537
3974
455
5939
222
734
770
9179
156
48
836
9865
293
759
677
9102
461
3772
388
5458
291
4197
142
2146
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
7.0e-01
8.6e-01
1.9e+00
—
2.3e+00
1.3e+00
8.3e-01
cases:4.74%
controls:2.42%
cases:2.12%
controls:0.91%
cases:0.71%
controls:0.11%
—
—
cases:0.72%
controls:0.07%
cases:3.18%
controls:0.87%
cases:6.00%
controls:2.71%
47
240
945
9673
21
90
971
9823
7
11
985
9902
—
7
7
963
9854
27
80
822
9150
26
172
407
6171
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
9.5e-01
1.3e+00
1.6e+00
—
2.5e+00
8.6e-01
6.4e-01
cases:26.71%
controls:12.37%
cases:18.75%
controls:5.82%
cases:3.33%
controls:0.71%
—
—
cases:6.29%
controls:0.56%
cases:13.90%
controls:6.40%
cases:31.64%
controls:19.68%
265
1226
727
8687
186
577
806
9336
33
70
959
9843
—
61
55
909
9806
118
591
731
8639
137
1248
296
5095
Pharmacy visit
OMOP4822462 [581458]
2.6e+00
1.8e+00
1.1e+00
1.4e+00
9.2e-01
4.0e-01
-8.5e-01
cases:99.80%
controls:97.42%
cases:98.89%
controls:93.46%
cases:81.85%
controls:60.24%
cases:12.20%
controls:3.35%
cases:79.07%
controls:60.14%
cases:95.88%
controls:93.97%
cases:95.84%
controls:98.17%
990
9657
2
256
981
9265
11
648
812
5972
180
3941
121
332
871
9581
767
5930
203
3931
814
8673
35
557
415
6227
18
116
Respiratory and circulatory monitoring
WX700 [2001310817]
9.4e-01
1.1e+00
—
—
2.8e+00
1.8e+00
1.0e+00
cases:6.45%
controls:2.61%
cases:2.52%
controls:0.83%
—
—
—
—
cases:0.82%
controls:0.05%
cases:3.53%
controls:0.62%
cases:7.39%
controls:2.84%
64
259
928
9654
25
82
967
9831
—
—
8
5
962
9856
30
57
819
9173
32
180
401
6163
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
2.3e+00
3.2e+00
—
1.0e+50
—
2.1e+00
1.1e+00
cases:5.04%
controls:0.52%
cases:4.33%
controls:0.19%
—
—
cases:0.81%
controls:0.00%
—
—
cases:2.59%
controls:0.31%
cases:2.77%
controls:0.95%
50
52
942
9861
43
19
949
9894
—
8
0
984
9913
—
22
29
827
9201
12
60
421
6283
potassium chloride; oral
A12BA01 [21600877]
7.9e-01
1.2e+00
1.7e+00
—
1.5e+00
1.3e+00
9.7e-01
cases:6.15%
controls:2.90%
cases:5.65%
controls:1.78%
cases:2.22%
controls:0.39%
—
—
cases:2.16%
controls:0.48%
cases:7.07%
controls:2.06%
cases:11.09%
controls:4.51%
61
287
931
9626
56
176
936
9737
22
39
970
9874
—
21
47
949
9814
60
190
789
9040
48
286
385
6057
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.6e+00
1.3e+00
2.5e+00
—
—
1.8e+00
1.5e+00
cases:2.42%
controls:0.47%
cases:1.01%
controls:0.28%
cases:0.60%
controls:0.05%
—
—
—
—
cases:1.41%
controls:0.23%
cases:3.00%
controls:0.69%
24
47
968
9866
10
28
982
9885
6
5
986
9908
—
—
12
21
837
9209
13
44
420
6299
Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]
1.1e+00
1.5e+00
—
—
2.1e+00
1.6e+00
1.2e+00
cases:2.52%
controls:0.87%
cases:2.12%
controls:0.48%
—
—
—
—
cases:0.72%
controls:0.09%
cases:2.47%
controls:0.51%
cases:6.47%
controls:2.03%
25
86
967
9827
21
48
971
9865
—
—
7
9
963
9852
21
47
828
9183
28
129
405
6214
Other specified urinary incontinence
N39.4 [45577525]
1.4e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.4e+00
cases:5.04%
controls:1.25%
cases:3.73%
controls:0.41%
—
—
cases:0.91%
controls:0.00%
—
—
cases:4.48%
controls:0.44%
cases:6.24%
controls:1.56%
50
124
942
9789
37
41
955
9872
—
9
0
983
9913
—
38
41
811
9189
27
99
406
6244
General symptom/complaint other
A29 [2002000163]
5.0e-01
1.2e+00
1.9e+00
—
2.0e+00
1.4e+00
1.0e+00
cases:3.73%
controls:2.29%
cases:2.82%
controls:0.91%
cases:1.51%
controls:0.23%
—
—
cases:1.44%
controls:0.20%
cases:4.12%
controls:1.04%
cases:9.24%
controls:3.53%
37
227
955
9686
28
90
964
9823
15
23
977
9890
—
14
20
956
9841
35
96
814
9134
40
224
393
6119
Decubitus ulcer and pressure area
L89 [45601235]
1.5e+00
2.2e+00
—
—
—
2.5e+00
2.7e+00
cases:0.50%
controls:0.11%
cases:0.71%
controls:0.08%
—
—
—
—
—
—
cases:0.82%
controls:0.07%
cases:3.70%
controls:0.25%
5
11
987
9902
7
8
985
9905
—
—
—
7
6
842
9224
16
16
417
6327
folic acid; oral, parenteral
B03BB01 [21601129]
9.2e-01
1.1e+00
1.5e+00
—
1.8e+00
1.3e+00
9.1e-01
cases:3.73%
controls:1.52%
cases:4.13%
controls:1.48%
cases:1.51%
controls:0.34%
—
—
cases:1.86%
controls:0.32%
cases:6.01%
controls:1.71%
cases:6.47%
controls:2.70%
37
151
955
9762
41
147
951
9766
15
34
977
9879
—
18
32
952
9829
51
158
798
9072
28
171
405
6172
folic acid
V04CX02 [715877]
9.2e-01
1.1e+00
1.5e+00
—
1.8e+00
1.3e+00
9.1e-01
cases:3.73%
controls:1.52%
cases:4.13%
controls:1.48%
cases:1.51%
controls:0.34%
—
—
cases:1.86%
controls:0.32%
cases:6.01%
controls:1.71%
cases:6.47%
controls:2.70%
37
151
955
9762
41
147
951
9766
15
34
977
9879
—
18
32
952
9829
51
158
798
9072
28
171
405
6172
Osmolality of Urine
2695-5 [3026782]
7.7e-01
1.2e+00
2.1e+00
—
2.0e+00
1.3e+00
4.8e-01
cases:12.20%
controls:6.05%
cases:7.26%
controls:2.40%
cases:2.62%
controls:0.31%
—
—
cases:2.78%
controls:0.39%
cases:8.48%
controls:2.45%
cases:12.47%
controls:8.10%
121
600
871
9313
72
238
920
9675
26
31
966
9882
—
27
38
943
9823
72
226
777
9004
54
514
379
5829
Essential (primary) hypertension
I10 [45591453]
1.2e-01
4.0e-01
9.6e-01
4.7e+00
9.2e-01
3.2e-01
-2.7e-01
cases:33.27%
controls:30.60%
cases:21.27%
controls:15.35%
cases:6.55%
controls:2.60%
cases:10.89%
controls:0.11%
cases:5.88%
controls:2.43%
cases:21.32%
controls:16.49%
cases:32.56%
controls:38.78%
330
3033
662
6880
211
1522
781
8391
65
258
927
9655
108
11
884
9902
57
240
913
9621
181
1522
668
7708
141
2460
292
3883
Acute cystitis
N30.0 [45601724]
1.2e+00
1.6e+00
1.8e+00
1.0e+50
—
1.4e+00
1.4e+00
cases:5.65%
controls:1.84%
cases:3.43%
controls:0.70%
cases:0.71%
controls:0.12%
cases:0.50%
controls:0.00%
—
—
cases:3.42%
controls:0.88%
cases:11.78%
controls:3.33%
56
182
936
9731
34
69
958
9844
7
12
985
9901
5
0
987
9913
—
29
81
820
9149
51
211
382
6132
Physiotherapist
Z3226 [2001311560]
1.1e+00
1.0e+00
3.0e+00
1.0e+50
—
1.4e+00
8.6e-01
cases:5.75%
controls:2.09%
cases:1.92%
controls:0.72%
cases:1.01%
controls:0.05%
cases:0.50%
controls:0.00%
—
—
cases:2.71%
controls:0.70%
cases:5.31%
controls:2.32%
57
207
935
9706
19
71
973
9842
10
5
982
9908
5
0
987
9913
—
23
65
826
9165
23
147
410
6196
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.3e-01
4.5e-01
1.1e+00
3.6e+00
1.4e+00
4.0e-01
-2.5e-02
cases:58.37%
controls:52.59%
cases:55.65%
controls:44.38%
cases:23.59%
controls:9.31%
cases:16.13%
controls:0.51%
cases:30.82%
controls:9.75%
cases:55.12%
controls:45.16%
cases:67.44%
controls:67.98%
579
5213
413
4700
552
4399
440
5514
234
923
758
8990
160
51
832
9862
299
961
671
8900
468
4168
381
5062
292
4312
141
2031
trospium; oral
G04BD09 [21602642]
1.9e+00
2.7e+00
—
—
—
2.6e+00
—
cases:2.32%
controls:0.34%
cases:1.01%
controls:0.07%
—
—
—
—
—
—
cases:0.71%
controls:0.05%
—
—
23
34
969
9879
10
7
982
9906
—
—
—
6
5
843
9225
—
Office Visit
OMOP4822458 [581477]
1.0e+00
1.1e+00
1.3e+00
—
2.4e+00
6.6e-01
6.7e-01
cases:17.94%
controls:7.34%
cases:5.75%
controls:2.04%
cases:1.11%
controls:0.29%
—
—
cases:2.37%
controls:0.22%
cases:4.12%
controls:2.17%
cases:11.09%
controls:5.98%
178
728
814
9185
57
202
935
9711
11
29
981
9884
—
23
22
947
9839
35
200
814
9030
48
379
385
5964
Other amnesia
R41.3 [45539342]
2.5e+00
2.6e+00
—
—
—
2.1e+00
2.0e+00
cases:1.41%
controls:0.12%
cases:0.91%
controls:0.07%
—
—
—
—
—
—
cases:0.94%
controls:0.12%
cases:1.15%
controls:0.16%
14
12
978
9901
9
7
983
9906
—
—
—
8
11
841
9219
5
10
428
6333
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
7.0e-01
1.1e+00
2.1e+00
—
1.9e+00
1.2e+00
3.5e-01
cases:14.62%
controls:7.87%
cases:10.69%
controls:3.66%
cases:3.73%
controls:0.46%
—
—
cases:3.71%
controls:0.58%
cases:11.78%
controls:3.82%
cases:15.70%
controls:11.62%
145
780
847
9133
106
363
886
9550
37
46
955
9867
—
36
57
934
9804
100
353
749
8877
68
737
365
5606
Case Management Agency
251B00000X [38004193]
6.4e-01
6.0e-01
9.1e-01
3.7e+00
8.6e-01
3.9e-01
-1.1e-01
cases:86.49%
controls:77.09%
cases:81.55%
controls:70.75%
cases:50.50%
controls:29.14%
cases:41.03%
controls:1.77%
cases:49.28%
controls:29.13%
cases:80.45%
controls:73.61%
cases:90.30%
controls:91.22%
858
7642
134
2271
809
7013
183
2900
501
2889
491
7024
407
175
585
9738
478
2873
492
6988
683
6794
166
2436
391
5786
42
557
MCH [Entitic mass]
28539-5 [3035941]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.6e-01
-7.7e-03
cases:58.47%
controls:53.43%
cases:55.75%
controls:44.75%
cases:24.29%
controls:9.69%
cases:16.94%
controls:0.56%
cases:32.58%
controls:9.96%
cases:56.89%
controls:45.46%
cases:68.13%
controls:68.30%
580
5297
412
4616
553
4436
439
5477
241
961
751
8952
168
56
824
9857
316
982
654
8879
483
4196
366
5034
295
4332
138
2011
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.6e-01
-8.4e-03
cases:58.47%
controls:53.51%
cases:55.75%
controls:44.78%
cases:24.29%
controls:9.69%
cases:16.94%
controls:0.56%
cases:32.47%
controls:9.96%
cases:56.89%
controls:45.53%
cases:68.13%
controls:68.31%
580
5304
412
4609
553
4439
439
5474
241
961
751
8952
168
56
824
9857
315
982
655
8879
483
4202
366
5028
295
4333
138
2010
Platelets [#/volume] in Blood
26515-7 [3007461]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.6e-01
-7.7e-03
cases:58.47%
controls:53.46%
cases:55.65%
controls:44.76%
cases:24.29%
controls:9.69%
cases:16.94%
controls:0.56%
cases:32.47%
controls:9.96%
cases:56.89%
controls:45.48%
cases:68.13%
controls:68.30%
580
5299
412
4614
552
4437
440
5476
241
961
751
8952
168
56
824
9857
315
982
655
8879
483
4198
366
5032
295
4332
138
2011
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.5e-01
-1.1e-02
cases:58.47%
controls:53.51%
cases:55.75%
controls:44.82%
cases:24.29%
controls:9.70%
cases:16.94%
controls:0.56%
cases:32.58%
controls:9.98%
cases:56.89%
controls:45.59%
cases:68.13%
controls:68.37%
580
5304
412
4609
553
4443
439
5470
241
962
751
8951
168
56
824
9857
316
984
654
8877
483
4208
366
5022
295
4337
138
2006
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.5e-01
-9.1e-03
cases:58.47%
controls:53.49%
cases:55.75%
controls:44.82%
cases:24.29%
controls:9.72%
cases:16.94%
controls:0.56%
cases:32.58%
controls:10.00%
cases:56.89%
controls:45.60%
cases:68.13%
controls:68.33%
580
5302
412
4611
553
4443
439
5470
241
964
751
8949
168
56
824
9857
316
986
654
8875
483
4209
366
5021
295
4334
138
2009
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.1e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.6e-01
-7.7e-03
cases:58.57%
controls:53.51%
cases:55.75%
controls:44.78%
cases:24.29%
controls:9.69%
cases:16.94%
controls:0.58%
cases:32.58%
controls:9.99%
cases:57.01%
controls:45.53%
cases:68.13%
controls:68.30%
581
5304
411
4609
553
4439
439
5474
241
961
751
8952
168
57
824
9856
316
985
654
8876
484
4202
365
5028
295
4332
138
2011
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.0e-01
4.4e-01
1.1e+00
3.6e+00
1.5e+00
4.5e-01
-1.5e-02
cases:58.47%
controls:53.55%
cases:55.75%
controls:44.82%
cases:24.29%
controls:9.72%
cases:16.94%
controls:0.58%
cases:32.58%
controls:10.02%
cases:56.89%
controls:45.66%
cases:68.13%
controls:68.45%
580
5308
412
4605
553
4443
439
5470
241
964
751
8949
168
57
824
9856
316
988
654
8873
483
4214
366
5016
295
4342
138
2001
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
7.3e-01
9.7e-01
1.6e+00
—
1.9e+00
1.3e+00
5.5e-01
cases:15.52%
controls:8.16%
cases:9.58%
controls:3.85%
cases:3.23%
controls:0.70%
—
—
cases:3.92%
controls:0.59%
cases:12.96%
controls:4.03%
cases:20.09%
controls:12.72%
154
809
838
9104
95
382
897
9531
32
69
960
9844
—
38
58
932
9803
110
372
739
8858
87
807
346
5536
Inpatient Visit
IP [9201]
6.4e-01
9.8e-01
1.5e+00
—
1.9e+00
1.2e+00
6.9e-01
cases:15.63%
controls:8.90%
cases:9.27%
controls:3.68%
cases:2.12%
controls:0.48%
—
—
cases:2.58%
controls:0.40%
cases:10.48%
controls:3.33%
cases:21.71%
controls:12.17%
155
882
837
9031
92
365
900
9548
21
48
971
9865
—
25
39
945
9822
89
307
760
8923
94
772
339
5571
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.8e-01
4.4e-01
1.0e+00
3.5e+00
1.3e+00
4.2e-01
-5.8e-02
cases:40.42%
controls:33.90%
cases:37.20%
controls:27.66%
cases:15.63%
controls:6.18%
cases:11.59%
controls:0.41%
cases:19.79%
controls:6.28%
cases:37.22%
controls:28.13%
cases:45.03%
controls:46.48%
401
3361
591
6552
369
2742
623
7171
155
613
837
9300
115
41
877
9872
192
619
778
9242
316
2596
533
6634
195
2948
238
3395
Bacteria [Presence] in Urine
87829-8 [36304419]
7.6e-01
9.5e-01
1.3e+00
—
2.0e+00
1.3e+00
5.4e-01
cases:14.82%
controls:7.50%
cases:8.77%
controls:3.58%
cases:2.52%
controls:0.69%
—
—
cases:3.71%
controls:0.52%
cases:11.90%
controls:3.62%
cases:18.01%
controls:11.32%
147
743
845
9170
87
355
905
9558
25
68
967
9845
—
36
51
934
9810
101
334
748
8896
78
718
355
5625
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
7.2e-01
9.4e-01
1.6e+00
—
1.9e+00
1.2e+00
4.7e-01
cases:17.64%
controls:9.44%
cases:10.89%
controls:4.57%
cases:3.93%
controls:0.81%
—
—
cases:4.54%
controls:0.72%
cases:14.96%
controls:4.86%
cases:21.94%
controls:14.96%
175
936
817
8977
108
453
884
9460
39
80
953
9833
—
44
71
926
9790
127
449
722
8781
95
949
338
5394
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
5.8e-01
7.7e-01
9.6e-01
2.6e+00
1.6e+00
2.9e-01
1.6e-01
cases:46.47%
controls:32.78%
cases:32.56%
controls:18.21%
cases:5.04%
controls:1.99%
cases:0.71%
controls:0.05%
cases:10.10%
controls:2.23%
cases:23.32%
controls:18.49%
cases:46.19%
controls:42.20%
461
3249
531
6664
323
1805
669
8108
50
197
942
9716
7
5
985
9908
98
220
872
9641
198
1707
651
7523
200
2677
233
3666
Unspecified urinary incontinence
R32 [45606803]
2.3e+00
2.4e+00
—
—
—
2.1e+00
1.5e+00
cases:1.81%
controls:0.19%
cases:1.11%
controls:0.10%
—
—
—
—
—
—
cases:0.82%
controls:0.10%
cases:1.15%
controls:0.27%
18
19
974
9894
11
10
981
9903
—
—
—
7
9
842
9221
5
17
428
6326
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
5.4e-01
1.0e+00
1.9e+00
—
1.8e+00
1.1e+00
5.4e-01
cases:18.95%
controls:12.02%
cases:15.02%
controls:5.95%
cases:4.94%
controls:0.81%
—
—
cases:5.05%
controls:0.91%
cases:16.49%
controls:6.24%
cases:26.56%
controls:17.47%
188
1192
804
8721
149
590
843
9323
49
80
943
9833
—
49
90
921
9771
140
576
709
8654
115
1108
318
5235
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
5.8e-01
1.0e+00
1.8e+00
—
1.7e+00
1.1e+00
5.4e-01
cases:23.19%
controls:14.51%
cases:19.46%
controls:7.81%
cases:6.35%
controls:1.13%
—
—
cases:6.29%
controls:1.21%
cases:22.03%
controls:8.48%
cases:33.95%
controls:23.03%
230
1438
762
8475
193
774
799
9139
63
112
929
9801
—
61
119
909
9742
187
783
662
8447
147
1461
286
4882
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
6.1e-01
1.0e+00
1.7e+00
—
1.7e+00
1.1e+00
5.3e-01
cases:23.39%
controls:14.26%
cases:19.35%
controls:7.80%
cases:6.15%
controls:1.13%
—
—
cases:6.29%
controls:1.23%
cases:22.03%
controls:8.52%
cases:33.95%
controls:23.16%
232
1414
760
8499
192
773
800
9140
61
112
931
9801
—
61
121
909
9740
187
786
662
8444
147
1469
286
4874
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
8.1e-01
1.4e+00
2.0e+00
—
1.1e+00
1.7e+00
8.8e-01
cases:6.45%
controls:2.98%
cases:3.83%
controls:1.00%
cases:1.61%
controls:0.23%
—
—
cases:0.72%
controls:0.24%
cases:4.95%
controls:0.95%
cases:8.08%
controls:3.52%
64
295
928
9618
38
99
954
9814
16
23
976
9890
—
7
24
963
9837
42
88
807
9142
35
223
398
6120
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5.9e-01
1.0e+00
1.8e+00
—
1.7e+00
1.1e+00
5.3e-01
cases:22.78%
controls:14.01%
cases:18.75%
controls:7.62%
cases:5.95%
controls:1.08%
—
—
cases:5.98%
controls:1.19%
cases:21.67%
controls:8.36%
cases:33.49%
controls:22.80%
226
1389
766
8524
186
755
806
9158
59
107
933
9806
—
58
117
912
9744
184
772
665
8458
145
1446
288
4897
Spinal stenosis
M48.0 [45557888]
1.3e+00
1.3e+00
9.6e-01
1.0e+50
1.7e+00
1.3e+00
1.1e+00
cases:7.96%
controls:2.32%
cases:3.53%
controls:1.02%
cases:0.60%
controls:0.23%
cases:1.41%
controls:0.00%
cases:1.13%
controls:0.21%
cases:4.12%
controls:1.16%
cases:8.08%
controls:2.74%
79
230
913
9683
35
101
957
9812
6
23
986
9890
14
0
978
9913
11
21
959
9840
35
107
814
9123
35
174
398
6169
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
7.1e-01
9.8e-01
1.4e+00
—
1.7e+00
1.2e+00
6.6e-01
cases:19.76%
controls:10.81%
cases:11.90%
controls:4.83%
cases:3.53%
controls:0.90%
—
—
cases:4.43%
controls:0.82%
cases:15.19%
controls:5.15%
cases:25.64%
controls:15.15%
196
1072
796
8841
118
479
874
9434
35
89
957
9824
—
43
81
927
9780
129
475
720
8755
111
961
322
5382
Tremor, unspecified
R25.1 [45539327]
4.0e+00
2.6e+00
—
—
—
—
-1.0e+50
cases:5.75%
controls:0.11%
cases:1.11%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
57
11
935
9902
11
8
981
9905
—
—
—
—
0
9
433
6334
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
7.5e-01
9.8e-01
2.1e+00
—
1.7e+00
1.0e+00
1.0e-01
cases:9.98%
controls:4.96%
cases:6.05%
controls:2.37%
cases:2.72%
controls:0.33%
—
—
cases:1.86%
controls:0.33%
cases:6.95%
controls:2.59%
cases:9.24%
controls:8.43%
99
492
893
9421
60
235
932
9678
27
33
965
9880
—
18
33
952
9828
59
239
790
8991
40
535
393
5808
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
3.3e-01
7.7e-01
1.7e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:11.29%
controls:8.36%
cases:6.85%
controls:3.30%
cases:2.32%
controls:0.44%
—
—
cases:2.27%
controls:0.34%
cases:10.60%
controls:3.52%
cases:27.48%
controls:11.32%
112
829
880
9084
68
327
924
9586
23
44
969
9869
—
22
34
948
9827
90
325
759
8905
119
718
314
5625
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
9.2e-01
1.2e+00
1.6e+00
—
2.0e+00
8.4e-01
2.2e-01
cases:13.31%
controls:5.78%
cases:7.06%
controls:2.20%
cases:1.11%
controls:0.22%
—
—
cases:1.86%
controls:0.25%
cases:5.06%
controls:2.25%
cases:9.93%
controls:8.12%
132
573
860
9340
70
218
922
9695
11
22
981
9891
—
18
25
952
9836
43
208
806
9022
43
515
390
5828
Pain general/multiple sites
A01 [2002000142]
1.1e+00
1.8e+00
2.5e+00
—
1.9e+00
1.2e+00
1.2e+00
cases:2.02%
controls:0.67%
cases:1.51%
controls:0.26%
cases:0.60%
controls:0.05%
—
—
cases:0.62%
controls:0.09%
cases:1.41%
controls:0.43%
cases:5.08%
controls:1.59%
20
66
972
9847
15
26
977
9887
6
5
986
9908
—
6
9
964
9852
12
40
837
9190
22
101
411
6242
pH of Arterial blood
2744-1 [3019977]
7.4e-01
1.0e+00
2.0e+00
—
1.8e+00
9.3e-01
5.8e-01
cases:4.84%
controls:2.36%
cases:2.82%
controls:1.04%
cases:0.81%
controls:0.11%
—
—
cases:0.82%
controls:0.13%
cases:2.36%
controls:0.94%
cases:6.93%
controls:3.99%
48
234
944
9679
28
103
964
9810
8
11
984
9902
—
8
13
962
9848
20
87
829
9143
30
253
403
6090
Base excess in Arterial blood by calculation
1925-7 [3003396]
7.8e-01
1.0e+00
1.9e+00
—
1.8e+00
9.9e-01
5.6e-01
cases:4.94%
controls:2.33%
cases:2.92%
controls:1.07%
cases:0.71%
controls:0.11%
—
—
cases:0.82%
controls:0.13%
cases:2.47%
controls:0.93%
cases:6.93%
controls:4.07%
49
231
943
9682
29
106
963
9807
7
11
985
9902
—
8
13
962
9848
21
86
828
9144
30
258
403
6085
INR in Blood by Coagulation assay
34714-6 [3032080]
5.2e-01
5.1e-01
7.9e-01
2.9e+00
5.7e-01
7.0e-01
4.7e-01
cases:25.50%
controls:16.88%
cases:14.62%
controls:9.29%
cases:7.96%
controls:3.79%
cases:4.13%
controls:0.24%
cases:6.49%
controls:3.77%
cases:17.31%
controls:9.44%
cases:31.41%
controls:22.20%
253
1673
739
8240
145
921
847
8992
79
376
913
9537
41
24
951
9889
63
372
907
9489
147
871
702
8359
136
1408
297
4935
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.4e-01
9.0e-01
1.7e+00
—
1.6e+00
9.7e-01
7.5e-01
cases:12.60%
controls:8.50%
cases:10.38%
controls:4.50%
cases:3.33%
controls:0.63%
—
—
cases:3.51%
controls:0.70%
cases:11.54%
controls:4.71%
cases:23.33%
controls:12.57%
125
843
867
9070
103
446
889
9467
33
62
959
9851
—
34
69
936
9792
98
435
751
8795
101
797
332
5546
Leukocytes [#/volume] in Urine
30405-5 [3018095]
6.9e-01
9.0e-01
1.5e+00
—
1.7e+00
1.1e+00
4.3e-01
cases:18.65%
controls:10.33%
cases:11.90%
controls:5.23%
cases:4.13%
controls:0.92%
—
—
cases:4.74%
controls:0.89%
cases:15.78%
controls:5.74%
cases:23.33%
controls:16.47%
185
1024
807
8889
118
518
874
9395
41
91
951
9822
—
46
88
924
9773
134
530
715
8700
101
1045
332
5298
12 lead EKG panel
34534-8 [3044889]
3.3e-01
3.5e-01
1.1e+00
3.4e+00
1.7e+00
2.8e-01
-4.7e-01
cases:35.99%
controls:28.73%
cases:20.06%
controls:15.07%
cases:4.44%
controls:1.46%
cases:1.71%
controls:0.06%
cases:7.42%
controls:1.51%
cases:17.79%
controls:14.08%
cases:24.94%
controls:34.79%
357
2848
635
7065
199
1494
793
8419
44
145
948
9768
17
6
975
9907
72
149
898
9712
151
1300
698
7930
108
2207
325
4136
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
6.7e-01
9.5e-01
1.7e+00
—
1.8e+00
1.2e+00
3.5e-01
cases:10.69%
controls:5.79%
cases:6.65%
controls:2.67%
cases:2.22%
controls:0.39%
—
—
cases:2.37%
controls:0.41%
cases:8.01%
controls:2.59%
cases:11.55%
controls:8.42%
106
574
886
9339
66
265
926
9648
22
39
970
9874
—
23
40
947
9821
68
239
781
8991
50
534
383
5809
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
6.5e-01
1.0e+00
1.8e+00
—
1.7e+00
1.0e+00
1.1e-01
cases:10.79%
controls:5.91%
cases:8.37%
controls:3.26%
cases:2.62%
controls:0.43%
—
—
cases:2.68%
controls:0.48%
cases:9.89%
controls:3.73%
cases:12.01%
controls:10.89%
107
586
885
9327
83
323
909
9590
26
43
966
9870
—
26
47
944
9814
84
344
765
8886
52
691
381
5652
pH of Urine
2756-5 [3015736]
5.3e-01
9.7e-01
1.6e+00
—
1.6e+00
1.1e+00
4.9e-01
cases:17.24%
controls:10.89%
cases:13.41%
controls:5.53%
cases:3.73%
controls:0.78%
—
—
cases:4.23%
controls:0.88%
cases:15.43%
controls:5.92%
cases:25.17%
controls:17.12%
171
1080
821
8833
133
548
859
9365
37
77
955
9836
—
41
87
929
9774
131
546
718
8684
109
1086
324
5257
Feeling depressed
P03 [2002000800]
2.3e+00
2.0e+00
—
—
—
—
1.9e+00
cases:1.41%
controls:0.14%
cases:0.91%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.20%
14
14
978
9899
9
12
983
9901
—
—
—
—
6
13
427
6330
trimethoprim; oral, parenteral
J01EA01 [21602931]
6.7e-01
1.1e+00
1.8e+00
—
5.5e-01
1.4e+00
1.3e+00
cases:11.09%
controls:6.02%
cases:6.55%
controls:2.25%
cases:1.81%
controls:0.30%
—
—
cases:0.72%
controls:0.42%
cases:9.19%
controls:2.46%
cases:23.09%
controls:7.73%
110
597
882
9316
65
223
927
9690
18
30
974
9883
—
7
41
963
9820
78
227
771
9003
100
490
333
5853
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
9.8e-02
2.5e-01
8.2e-01
3.6e+00
1.2e+00
3.0e-01
-6.4e-02
cases:40.22%
controls:37.89%
cases:37.90%
controls:32.21%
cases:14.62%
controls:6.98%
cases:10.69%
controls:0.32%
cases:21.13%
controls:7.30%
cases:40.52%
controls:33.61%
cases:51.27%
controls:52.88%
399
3756
593
6157
376
3193
616
6720
145
692
847
9221
106
32
886
9881
205
720
765
9141
344
3102
505
6128
222
3354
211
2989
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
8.8e-01
1.6e+00
—
—
—
2.1e+00
1.6e+00
cases:2.12%
controls:0.89%
cases:1.92%
controls:0.40%
—
—
—
—
—
—
cases:2.47%
controls:0.31%
cases:7.85%
controls:1.67%
21
88
971
9825
19
40
973
9873
—
—
—
21
29
828
9201
34
106
399
6237
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.3e+00
1.2e+00
1.8e+00
—
1.6e+00
1.7e+00
2.0e+00
cases:4.33%
controls:1.20%
cases:1.71%
controls:0.53%
cases:0.50%
controls:0.08%
—
—
cases:0.62%
controls:0.12%
cases:3.18%
controls:0.60%
cases:6.70%
controls:1.01%
43
119
949
9794
17
53
975
9860
5
8
987
9905
—
6
12
964
9849
27
55
822
9175
29
64
404
6279
Atrial fibrillation and flutter
I48 [45596206]
3.2e-01
5.1e-01
7.7e-01
4.0e+00
6.9e-01
4.8e-01
6.6e-02
cases:16.83%
controls:12.80%
cases:10.89%
controls:6.85%
cases:3.13%
controls:1.47%
cases:3.63%
controls:0.07%
cases:2.78%
controls:1.41%
cases:11.07%
controls:7.14%
cases:16.86%
controls:15.95%
167
1269
825
8644
108
679
884
9234
31
146
961
9767
36
7
956
9906
27
139
943
9722
94
659
755
8571
73
1012
360
5331
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
5.0e-01
7.9e-01
1.7e+00
—
2.2e+00
8.2e-01
2.7e-01
cases:20.87%
controls:13.81%
cases:11.49%
controls:5.59%
cases:2.82%
controls:0.52%
—
—
cases:4.85%
controls:0.55%
cases:11.19%
controls:5.24%
cases:20.32%
controls:16.30%
207
1369
785
8544
114
554
878
9359
28
52
964
9861
—
47
54
923
9807
95
484
754
8746
88
1034
345
5309
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
7.4e-01
9.5e-01
1.3e+00
—
1.8e+00
1.3e+00
4.2e-01
cases:8.87%
controls:4.46%
cases:5.04%
controls:2.01%
cases:1.61%
controls:0.45%
—
—
cases:2.16%
controls:0.37%
cases:7.77%
controls:2.32%
cases:10.85%
controls:7.38%
88
442
904
9471
50
199
942
9714
16
45
976
9868
—
21
36
949
9825
66
214
783
9016
47
468
386
5875
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
1.6e+00
2.5e+00
—
—
—
1.9e+00
1.2e+00
cases:1.81%
controls:0.37%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
cases:1.41%
controls:0.21%
cases:1.85%
controls:0.57%
18
37
974
9876
6
5
986
9908
—
—
—
12
19
837
9211
8
36
425
6307
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
1.6e+00
2.5e+00
—
—
—
1.9e+00
1.2e+00
cases:1.81%
controls:0.37%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
cases:1.41%
controls:0.21%
cases:1.85%
controls:0.57%
18
37
974
9876
6
5
986
9908
—
—
—
12
19
837
9211
8
36
425
6307
Laboratory Visit
OMOP4822461 [32036]
1.6e-01
3.6e-01
8.8e-01
3.2e+00
1.2e+00
3.5e-01
-1.1e-01
cases:60.38%
controls:56.53%
cases:61.19%
controls:52.31%
cases:32.36%
controls:16.53%
cases:20.77%
controls:1.05%
cases:40.31%
controls:16.92%
cases:61.84%
controls:53.43%
cases:69.28%
controls:71.64%
599
5604
393
4309
607
5185
385
4728
321
1639
671
8274
206
104
786
9809
391
1668
579
8193
525
4932
324
4298
300
4544
133
1799
pH of Serum or Plasma
2753-2 [3018418]
8.7e-01
1.2e+00
1.4e+00
—
1.8e+00
7.7e-01
2.0e-01
cases:16.53%
controls:7.66%
cases:12.80%
controls:4.30%
cases:2.82%
controls:0.72%
—
—
cases:4.74%
controls:0.84%
cases:9.19%
controls:4.46%
cases:14.09%
controls:11.89%
164
759
828
9154
127
426
865
9487
28
71
964
9842
—
46
83
924
9778
78
412
771
8818
61
754
372
5589
Unspecified osteoporosis with pathological fracture
M80.9 [45553292]
1.8e+00
1.8e+00
—
—
—
2.5e+00
1.6e+00
cases:1.11%
controls:0.18%
cases:0.60%
controls:0.10%
—
—
—
—
—
—
cases:0.94%
controls:0.08%
cases:1.85%
controls:0.38%
11
18
981
9895
6
10
986
9903
—
—
—
8
7
841
9223
8
24
425
6319
Homocysteine [Moles/volume] in Serum or Plasma
13965-9 [3016724]
2.9e+00
—
—
—
—
1.0e+50
3.0e+00
cases:1.81%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.00%
cases:1.62%
controls:0.08%
18
10
974
9903
—
—
—
—
7
0
842
9230
7
5
426
6338
Shoulder X-ray examination without contrast
NB1AA [2001307225]
1.0e+00
1.9e+00
—
—
—
1.4e+00
1.5e+00
cases:2.02%
controls:0.72%
cases:1.51%
controls:0.22%
—
—
—
—
—
—
cases:1.18%
controls:0.28%
cases:3.00%
controls:0.68%
20
71
972
9842
15
22
977
9891
—
—
—
10
26
839
9204
13
43
420
6300
Syncope and collapse
R55 [45568141]
1.4e+00
1.8e+00
—
—
—
1.7e+00
1.0e+00
cases:4.84%
controls:1.25%
cases:2.82%
controls:0.47%
—
—
—
—
—
—
cases:2.59%
controls:0.48%
cases:5.54%
controls:2.11%
48
124
944
9789
28
47
964
9866
—
—
—
22
44
827
9186
24
134
409
6209
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.0e-01
3.3e-01
8.9e-01
3.4e+00
9.9e-01
3.0e-01
8.4e-02
cases:17.54%
controls:13.66%
cases:14.42%
controls:10.83%
cases:5.85%
controls:2.49%
cases:3.23%
controls:0.11%
cases:6.91%
controls:2.69%
cases:14.61%
controls:11.20%
cases:21.48%
controls:20.10%
174
1354
818
8559
143
1074
849
8839
58
247
934
9666
32
11
960
9902
67
265
903
9596
124
1034
725
8196
93
1275
340
5068
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
1.3e+00
9.4e-01
2.0e+00
—
1.9e+00
1.4e+00
1.2e+00
cases:2.52%
controls:0.68%
cases:1.31%
controls:0.51%
cases:0.81%
controls:0.11%
—
—
cases:0.62%
controls:0.09%
cases:2.71%
controls:0.67%
cases:7.16%
controls:2.36%
25
67
967
9846
13
51
979
9862
8
11
984
9902
—
6
9
964
9852
23
62
826
9168
31
150
402
6193
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
6.4e-01
8.4e-01
1.1e+00
1.5e+00
1.1e+00
1.1e+00
1.0e+00
cases:56.96%
controls:40.98%
cases:42.64%
controls:24.30%
cases:13.71%
controls:4.96%
cases:0.60%
controls:0.14%
cases:13.51%
controls:4.83%
cases:50.06%
controls:25.05%
cases:73.67%
controls:49.85%
565
4062
427
5851
423
2409
569
7504
136
492
856
9421
6
14
986
9899
131
476
839
9385
425
2312
424
6918
319
3162
114
3181
Polyuria
R35 [45539331]
1.8e+00
2.1e+00
—
—
—
1.9e+00
6.1e-01
cases:5.54%
controls:0.96%
cases:2.82%
controls:0.34%
—
—
—
—
—
—
cases:1.88%
controls:0.28%
cases:2.08%
controls:1.14%
55
95
937
9818
28
34
964
9879
—
—
—
16
26
833
9204
9
72
424
6271
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.3e-01
2.9e-01
9.2e-01
3.4e+00
1.2e+00
2.2e-01
-1.3e-01
cases:40.93%
controls:37.91%
cases:35.48%
controls:29.22%
cases:14.11%
controls:6.16%
cases:9.98%
controls:0.38%
cases:18.76%
controls:6.23%
cases:34.28%
controls:29.58%
cases:45.73%
controls:49.01%
406
3758
586
6155
352
2897
640
7016
140
611
852
9302
99
38
893
9875
182
614
788
9247
291
2730
558
6500
198
3109
235
3234
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
7.0e-01
9.4e-01
1.3e+00
—
1.7e+00
1.2e+00
4.9e-01
cases:8.47%
controls:4.40%
cases:5.54%
controls:2.24%
cases:1.71%
controls:0.47%
—
—
cases:2.06%
controls:0.40%
cases:7.89%
controls:2.51%
cases:12.47%
controls:8.04%
84
436
908
9477
55
222
937
9691
17
47
975
9866
—
20
39
950
9822
67
232
782
8998
54
510
379
5833
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
8.5e-01
9.7e-01
9.9e-01
—
2.2e+00
1.0e+00
7.7e-01
cases:14.11%
controls:6.59%
cases:8.06%
controls:3.22%
cases:1.21%
controls:0.45%
—
—
cases:3.61%
controls:0.43%
cases:9.54%
controls:3.72%
cases:21.25%
controls:11.07%
140
653
852
9260
80
319
912
9594
12
45
980
9868
—
35
42
935
9819
81
343
768
8887
92
702
341
5641
Constipation, unspecified
K59.09 [2000502926]
1.8e+00
2.0e+00
—
—
—
1.9e+00
5.9e-01
cases:4.54%
controls:0.79%
cases:2.82%
controls:0.37%
—
—
—
—
—
—
cases:2.59%
controls:0.41%
cases:2.77%
controls:1.56%
45
78
947
9835
28
37
964
9876
—
—
—
22
38
827
9192
12
99
421
6244
Constipation caused by slow bowel passage (SCT)
K59.00 [2000502924]
1.4e+00
2.3e+00
—
—
—
2.0e+00
—
cases:1.11%
controls:0.28%
cases:0.60%
controls:0.06%
—
—
—
—
—
—
cases:0.71%
controls:0.10%
—
—
11
28
981
9885
6
6
986
9907
—
—
—
6
9
843
9221
—
Specific gravity of Urine by Refractometry
5810-7 [3019150]
4.1e-01
8.7e-01
1.7e+00
—
1.8e+00
8.7e-01
4.5e-01
cases:9.58%
controls:6.59%
cases:8.47%
controls:3.74%
cases:2.72%
controls:0.52%
—
—
cases:2.89%
controls:0.49%
cases:8.95%
controls:3.97%
cases:15.94%
controls:10.75%
95
653
897
9260
84
371
908
9542
27
52
965
9861
—
28
48
942
9813
76
366
773
8864
69
682
364
5661
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
4.3e-01
9.0e-01
1.6e+00
—
1.6e+00
1.0e+00
3.7e-01
cases:10.48%
controls:7.11%
cases:6.55%
controls:2.76%
cases:1.71%
controls:0.35%
—
—
cases:2.06%
controls:0.41%
cases:7.30%
controls:2.75%
cases:14.09%
controls:10.22%
104
705
888
9208
65
274
927
9639
17
35
975
9878
—
20
40
950
9821
62
254
787
8976
61
648
372
5695
pivmecillinam; oral
J01CA08 [21602827]
6.7e-01
1.1e+00
1.1e+00
—
1.5e+00
1.1e+00
1.1e+00
cases:13.10%
controls:7.18%
cases:7.36%
controls:2.59%
cases:1.21%
controls:0.40%
—
—
cases:1.13%
controls:0.25%
cases:8.01%
controls:2.70%
cases:20.79%
controls:7.71%
130
712
862
9201
73
257
919
9656
12
40
980
9873
—
11
25
959
9836
68
249
781
8981
90
489
343
5854
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
2.7e+00
2.9e+00
—
1.0e+50
—
—
1.6e+00
cases:4.44%
controls:0.32%
cases:1.61%
controls:0.09%
—
—
cases:0.50%
controls:0.00%
—
—
—
—
cases:1.62%
controls:0.35%
44
32
948
9881
16
9
976
9904
—
5
0
987
9913
—
—
7
22
426
6321
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
1.0e+00
1.1e+00
2.3e+00
—
—
1.1e+00
4.9e-01
cases:3.02%
controls:1.10%
cases:1.61%
controls:0.53%
cases:0.81%
controls:0.08%
—
—
—
—
cases:1.88%
controls:0.65%
cases:4.62%
controls:2.89%
30
109
962
9804
16
53
976
9860
8
8
984
9905
—
—
16
60
833
9170
20
183
413
6160
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
9.8e-01
1.2e+00
1.6e+00
—
2.2e+00
1.1e+00
4.1e-01
cases:5.54%
controls:2.16%
cases:4.03%
controls:1.24%
cases:0.81%
controls:0.17%
—
—
cases:1.96%
controls:0.21%
cases:3.18%
controls:1.07%
cases:4.85%
controls:3.26%
55
214
937
9699
40
123
952
9790
8
17
984
9896
—
19
21
951
9840
27
99
822
9131
21
207
412
6136
Physiotherapy
R4110 [2001310233]
8.2e-01
9.1e-01
1.8e+00
—
1.4e+00
1.2e+00
7.8e-01
cases:11.79%
controls:5.55%
cases:4.94%
controls:2.06%
cases:1.31%
controls:0.22%
—
—
cases:0.82%
controls:0.20%
cases:5.89%
controls:1.81%
cases:11.78%
controls:5.75%
117
550
875
9363
49
204
943
9709
13
22
979
9891
—
8
20
962
9841
50
167
799
9063
51
365
382
5978
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
7.9e-01
1.0e+00
1.9e+00
—
1.8e+00
8.5e-01
5.6e-01
cases:4.94%
controls:2.30%
cases:2.92%
controls:1.08%
cases:0.71%
controls:0.11%
—
—
cases:0.82%
controls:0.13%
cases:2.24%
controls:0.96%
cases:6.93%
controls:4.08%
49
228
943
9685
29
107
963
9806
7
11
985
9902
—
8
13
962
9848
19
89
830
9141
30
259
403
6084
Memory test
SPAT1053 [2001700154]
1.4e+00
2.0e+00
1.5e+00
—
1.4e+00
1.1e+00
9.3e-01
cases:12.50%
controls:3.37%
cases:5.65%
controls:0.79%
cases:0.81%
controls:0.18%
—
—
cases:0.62%
controls:0.15%
cases:3.06%
controls:1.00%
cases:9.24%
controls:3.88%
124
334
868
9579
56
78
936
9835
8
18
984
9895
—
6
15
964
9846
26
92
823
9138
40
246
393
6097
Fracture: other
L76 [2002000695]
1.7e+00
2.2e+00
—
—
—
—
1.6e+00
cases:0.91%
controls:0.16%
cases:0.91%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.39%
9
16
983
9897
9
10
983
9903
—
—
—
—
8
25
425
6318
Pelvis X-ray examination
NE1AA [2001307792]
1.0e+00
1.8e+00
—
—
-1.0e+50
1.4e+00
1.2e+00
cases:2.92%
controls:1.10%
cases:1.71%
controls:0.28%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.88%
controls:0.46%
cases:4.85%
controls:1.45%
29
109
963
9804
17
28
975
9885
—
—
0
6
970
9855
16
42
833
9188
21
92
412
6251
Occupational therapy functional assessment compilation tool
440362002 [4234641]
2.3e+00
—
—
—
—
—
3.2e+00
cases:1.01%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.08%
10
10
982
9903
—
—
—
—
—
8
5
425
6338
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
6.3e-01
8.2e-01
1.0e+00
—
2.2e+00
8.3e-01
1.2e-01
cases:17.34%
controls:10.03%
cases:11.69%
controls:5.53%
cases:1.41%
controls:0.50%
—
—
cases:5.15%
controls:0.62%
cases:11.54%
controls:5.41%
cases:17.78%
controls:16.10%
172
994
820
8919
116
548
876
9365
14
50
978
9863
—
50
61
920
9800
98
499
751
8731
77
1021
356
5322
Sampling
SPAT1263 [2001700364]
5.5e-01
9.7e-01
1.3e+00
-1.0e+50
9.6e-01
1.0e+00
6.5e-01
cases:17.94%
controls:11.16%
cases:10.48%
controls:4.26%
cases:3.83%
controls:1.07%
cases:0.00%
controls:0.06%
cases:2.58%
controls:1.00%
cases:11.31%
controls:4.34%
cases:20.55%
controls:11.90%
178
1106
814
8807
104
422
888
9491
38
106
954
9807
0
6
992
9907
25
99
945
9762
96
401
753
8829
89
755
344
5588
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
7.9e-01
1.0e+00
1.8e+00
—
1.8e+00
8.5e-01
5.6e-01
cases:4.94%
controls:2.30%
cases:2.92%
controls:1.08%
cases:0.71%
controls:0.12%
—
—
cases:0.82%
controls:0.13%
cases:2.24%
controls:0.96%
cases:6.93%
controls:4.08%
49
228
943
9685
29
107
963
9806
7
12
985
9901
—
8
13
962
9848
19
89
830
9141
30
259
403
6084
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
3.0e+00
—
—
—
—
—
2.4e+00
cases:1.61%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.11%
16
8
976
9905
—
—
—
—
—
5
7
428
6336
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
7.2e-01
1.4e+00
—
1.0e+50
1.9e+00
1.3e+00
1.5e-01
cases:2.82%
controls:1.39%
cases:2.22%
controls:0.56%
—
—
cases:0.60%
controls:0.00%
cases:0.82%
controls:0.12%
cases:2.36%
controls:0.63%
cases:3.00%
controls:2.60%
28
138
964
9775
22
56
970
9857
—
6
0
986
9913
8
12
962
9849
20
58
829
9172
13
165
420
6178
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.2e+00
1.3e+00
—
—
—
1.6e+00
1.2e+00
cases:3.83%
controls:1.13%
cases:1.61%
controls:0.43%
—
—
—
—
—
—
cases:1.65%
controls:0.35%
cases:3.46%
controls:1.07%
38
112
954
9801
16
43
976
9870
—
—
—
14
32
835
9198
15
68
418
6275
Assessment of adjustments needed in living environment
SPAT1231 [2001700332]
2.9e+00
—
—
—
—
—
2.5e+00
cases:2.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:3.23%
controls:0.28%
24
14
968
9899
—
—
—
—
—
14
18
419
6325
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.0e-01
7.2e-01
1.0e+00
—
1.6e+00
8.1e-01
4.9e-01
cases:21.88%
controls:12.25%
cases:12.80%
controls:6.68%
cases:3.53%
controls:1.30%
—
—
cases:5.26%
controls:1.13%
cases:14.37%
controls:6.96%
cases:25.40%
controls:17.22%
217
1214
775
8699
127
662
865
9251
35
129
957
9784
—
51
111
919
9750
122
642
727
8588
110
1092
323
5251
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
8.1e-01
1.1e+00
2.2e+00
—
1.4e+00
1.2e+00
5.1e-01
cases:3.02%
controls:1.37%
cases:1.81%
controls:0.61%
cases:0.81%
controls:0.09%
—
—
cases:0.52%
controls:0.13%
cases:2.36%
controls:0.72%
cases:5.31%
controls:3.26%
30
136
962
9777
18
60
974
9853
8
9
984
9904
—
5
13
965
9848
20
66
829
9164
23
207
410
6136
Psychological sympt/compl other
P29 [2002000823]
2.8e+00
—
—
—
—
2.5e+00
—
cases:1.11%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.09%
—
—
11
7
981
9906
—
—
—
—
9
8
840
9222
—
Disorientation, unspecified
R41.0 [45558469]
3.1e+00
—
1.0e+50
1.0e+50
—
—
2.2e+00
cases:2.42%
controls:0.11%
—
—
cases:1.01%
controls:0.00%
cases:0.71%
controls:0.00%
—
—
—
—
cases:1.62%
controls:0.19%
24
11
968
9902
—
10
0
982
9913
7
0
985
9913
—
—
7
12
426
6331
Urine culture
117010004 [4024509]
—
1.7e+00
2.1e+00
—
—
1.5e+00
7.1e-01
—
—
cases:1.51%
controls:0.29%
cases:0.71%
controls:0.09%
—
—
—
—
cases:2.47%
controls:0.54%
cases:3.00%
controls:1.50%
—
15
29
977
9884
7
9
985
9904
—
—
21
50
828
9180
13
95
420
6248
fesoterodine; oral
G04BD11 [21602644]
1.4e+00
1.9e+00
—
—
-1.0e+50
1.9e+00
1.3e+00
cases:1.92%
controls:0.46%
cases:0.91%
controls:0.13%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.18%
controls:0.18%
cases:1.62%
controls:0.46%
19
46
973
9867
9
13
983
9900
—
—
0
5
970
9856
10
17
839
9213
7
29
426
6314
Specific gravity of Urine by Test strip
5811-5 [3000330]
7.1e-01
1.1e+00
2.3e+00
—
1.6e+00
1.1e+00
-2.1e-02
cases:3.93%
controls:1.97%
cases:3.02%
controls:0.98%
cases:1.01%
controls:0.10%
—
—
cases:0.82%
controls:0.17%
cases:2.94%
controls:1.04%
cases:3.93%
controls:4.00%
39
195
953
9718
30
97
962
9816
10
10
982
9903
—
8
17
962
9844
25
96
824
9134
17
254
416
6089
Exposure to unspecified factor
X59 [45756412]
6.6e-01
1.1e+00
2.2e+00
—
—
9.7e-01
1.3e+00
cases:3.33%
controls:1.76%
cases:1.71%
controls:0.59%
cases:0.60%
controls:0.07%
—
—
—
—
cases:1.53%
controls:0.59%
cases:7.62%
controls:2.13%
33
174
959
9739
17
58
975
9855
6
7
986
9906
—
—
13
54
836
9176
33
135
400
6208
Unspecified dementia
F03 [45566772]
—
—
1.0e+50
—
—
2.9e+00
2.3e+00
—
—
—
—
cases:0.71%
controls:0.00%
—
—
—
—
cases:1.53%
controls:0.09%
cases:1.62%
controls:0.16%
—
—
7
0
985
9913
—
—
13
8
836
9222
7
10
426
6333
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.4e-01
4.1e-01
7.2e-01
2.1e+00
9.1e-01
5.8e-01
4.7e-01
cases:18.15%
controls:14.82%
cases:12.00%
controls:8.31%
cases:3.93%
controls:1.96%
cases:1.01%
controls:0.12%
cases:4.74%
controls:1.97%
cases:13.78%
controls:8.22%
cases:28.18%
controls:19.64%
180
1469
812
8444
119
824
873
9089
39
194
953
9719
10
12
982
9901
46
194
924
9667
117
759
732
8471
122
1246
311
5097
pH of Specimen
17433-4 [3019225]
5.1e-01
8.8e-01
1.4e+00
—
2.5e+00
8.5e-01
9.4e-01
cases:5.14%
controls:3.14%
cases:3.83%
controls:1.62%
cases:1.01%
controls:0.26%
—
—
cases:2.27%
controls:0.18%
cases:3.30%
controls:1.44%
cases:7.62%
controls:3.12%
51
311
941
9602
38
161
954
9752
10
26
982
9887
—
22
18
948
9843
28
133
821
9097
33
198
400
6145
Physiologic investigation of micturition
XKD06 [2001306098]
2.7e+00
2.5e+00
—
—
—
—
—
cases:2.52%
controls:0.17%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
25
17
967
9896
6
5
986
9908
—
—
—
—
—
Accident at home
Y94.0 [2000503726]
2.0e+00
—
—
—
—
—
3.2e+00
cases:1.01%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.08%
10
14
982
9899
—
—
—
—
—
8
5
425
6338
donepezil; oral
N06DA02 [21604795]
—
1.0e+50
1.0e+50
—
—
5.1e+00
—
—
—
cases:5.85%
controls:0.00%
cases:2.02%
controls:0.00%
—
—
—
—
cases:8.01%
controls:0.05%
—
—
—
58
0
934
9913
20
0
972
9913
—
—
68
5
781
9225
—
Cystitis, unspecified
N30.9 [45606488]
7.0e-01
1.5e+00
—
—
—
2.1e+00
1.4e+00
cases:1.31%
controls:0.66%
cases:1.01%
controls:0.23%
—
—
—
—
—
—
cases:2.12%
controls:0.26%
cases:4.62%
controls:1.17%
13
65
979
9848
10
23
982
9890
—
—
—
18
24
831
9206
20
74
413
6269
Vancomycin [Susceptibility]
19000-9 [3014271]
2.0e+00
—
—
—
—
—
2.9e+00
cases:0.60%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:2.31%
controls:0.13%
6
8
986
9905
—
—
—
—
—
10
8
423
6335
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.1e-01
4.6e-01
5.6e-01
2.1e+00
1.0e+00
4.6e-01
3.0e-01
cases:33.67%
controls:27.21%
cases:24.09%
controls:16.71%
cases:5.85%
controls:3.43%
cases:1.41%
controls:0.17%
cases:8.87%
controls:3.36%
cases:23.91%
controls:16.62%
cases:41.80%
controls:34.84%
334
2697
658
7216
239
1656
753
8257
58
340
934
9573
14
17
978
9896
86
331
884
9530
203
1534
646
7696
181
2210
252
4133
Hypotension, unspecified
I95.9 [45572153]
2.6e+00
—
—
—
—
2.1e+00
2.3e+00
cases:1.21%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.08%
cases:1.85%
controls:0.19%
12
9
980
9904
—
—
—
—
5
7
844
9223
8
12
425
6331
Urgent procedure
ZXD05 [2001311386]
4.7e-01
4.9e-01
2.8e+00
1.0e+50
—
8.7e-01
7.7e-01
cases:6.85%
controls:4.38%
cases:2.12%
controls:1.30%
cases:0.81%
controls:0.05%
cases:0.50%
controls:0.00%
—
—
cases:2.59%
controls:1.11%
cases:8.78%
controls:4.26%
68
434
924
9479
21
129
971
9784
8
5
984
9908
5
0
987
9913
—
22
102
827
9128
38
270
395
6073
Constipation
K59.0 [45557663]
1.5e+00
2.0e+00
—
—
—
7.8e-01
1.4e+00
cases:2.92%
controls:0.64%
cases:1.21%
controls:0.17%
—
—
—
—
—
—
cases:0.59%
controls:0.27%
cases:3.46%
controls:0.91%
29
63
963
9850
12
17
980
9896
—
—
—
5
25
844
9205
15
58
418
6285
Hip X-ray examination
NF1AA [2001307894]
7.3e-01
1.4e+00
—
—
-1.0e+50
1.4e+00
1.3e+00
cases:3.23%
controls:1.57%
cases:1.71%
controls:0.41%
—
—
—
—
cases:0.00%
controls:0.06%
cases:2.00%
controls:0.49%
cases:6.70%
controls:1.97%
32
156
960
9757
17
41
975
9872
—
—
0
6
970
9855
17
45
832
9185
29
125
404
6218
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.4e-01
6.8e-01
1.3e+00
—
1.5e+00
6.6e-01
2.7e-01
cases:12.30%
controls:6.26%
cases:5.54%
controls:2.88%
cases:1.31%
controls:0.37%
—
—
cases:1.55%
controls:0.35%
cases:4.71%
controls:2.48%
cases:9.93%
controls:7.77%
122
621
870
9292
55
285
937
9628
13
37
979
9876
—
15
35
955
9826
40
229
809
9001
43
493
390
5850
Voice symptom/complaint
R23 [2002000892]
2.3e+00
—
—
—
—
—
2.5e+00
cases:1.21%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.09%
12
12
980
9901
—
—
—
—
—
5
6
428
6337
Asthma, unspecified
J45.9 [45562456]
4.2e-01
7.3e-01
1.4e+00
—
1.7e+00
9.7e-01
4.4e-01
cases:5.44%
controls:3.65%
cases:3.53%
controls:1.73%
cases:1.11%
controls:0.27%
—
—
cases:1.55%
controls:0.28%
cases:4.36%
controls:1.70%
cases:6.00%
controls:3.94%
54
362
938
9551
35
171
957
9742
11
27
981
9886
—
15
28
955
9833
37
157
812
9073
26
250
407
6093
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.3e+00
1.4e+00
—
—
2.2e+00
8.2e-01
7.0e-01
cases:2.72%
controls:0.79%
cases:2.02%
controls:0.52%
—
—
—
—
cases:0.72%
controls:0.08%
cases:1.41%
controls:0.63%
cases:4.16%
controls:2.11%
27
78
965
9835
20
52
972
9861
—
—
7
8
963
9853
12
58
837
9172
18
134
415
6209
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
9.7e-01
1.2e+00
—
—
1.8e+00
9.1e-01
8.7e-01
cases:3.53%
controls:1.36%
cases:2.12%
controls:0.65%
—
—
—
—
cases:0.82%
controls:0.14%
cases:1.65%
controls:0.67%
cases:4.39%
controls:1.89%
35
135
957
9778
21
64
971
9849
—
—
8
14
962
9847
14
62
835
9168
19
120
414
6223
nitrofurantoin; oral
J01XE01 [21603058]
7.1e-01
1.4e+00
—
—
—
1.5e+00
1.1e+00
cases:4.44%
controls:2.23%
cases:2.82%
controls:0.69%
—
—
—
—
—
—
cases:2.71%
controls:0.61%
cases:8.78%
controls:2.98%
44
221
948
9692
28
68
964
9845
—
—
—
23
56
826
9174
38
189
395
6154
pH of Capillary blood
2745-8 [3009343]
1.3e+00
1.3e+00
—
—
2.2e+00
8.7e-01
7.4e-01
cases:2.72%
controls:0.78%
cases:1.92%
controls:0.51%
—
—
—
—
cases:0.72%
controls:0.08%
cases:1.41%
controls:0.60%
cases:4.16%
controls:2.02%
27
77
965
9836
19
51
973
9862
—
—
7
8
963
9853
12
55
837
9175
18
128
415
6215
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
5.3e-01
1.8e+00
—
—
—
1.6e+00
1.4e+00
cases:1.21%
controls:0.72%
cases:1.51%
controls:0.26%
—
—
—
—
—
—
cases:1.65%
controls:0.34%
cases:4.16%
controls:1.06%
12
71
980
9842
15
26
977
9887
—
—
—
14
31
835
9199
18
67
415
6276
carbamazepine; oral, rectal
N03AF01 [21604417]
2.3e+00
2.5e+00
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:0.71%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
7
7
985
9906
7
6
985
9907
—
—
—
—
—
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.4e+00
1.6e+00
—
—
—
1.7e+00
8.8e-01
cases:2.62%
controls:0.65%
cases:1.41%
controls:0.28%
—
—
—
—
—
—
cases:0.94%
controls:0.17%
cases:1.85%
controls:0.77%
26
64
966
9849
14
28
978
9885
—
—
—
8
16
841
9214
8
49
425
6294
Other and unspecified abdominal pain
R10.4 [45568113]
5.9e-01
1.1e+00
7.4e-01
—
2.0e+00
9.6e-01
4.1e-01
cases:7.56%
controls:4.36%
cases:3.83%
controls:1.25%
cases:0.50%
controls:0.24%
—
—
cases:0.93%
controls:0.12%
cases:3.65%
controls:1.43%
cases:8.08%
controls:5.52%
75
432
917
9481
38
124
954
9789
5
24
987
9889
—
9
12
961
9849
31
132
818
9098
35
350
398
5993
Stoma care and guidance
SPAT1125 [2001700226]
—
1.2e+00
—
—
—
2.5e+00
2.2e+00
—
—
cases:0.50%
controls:0.15%
—
—
—
—
—
—
cases:1.65%
controls:0.14%
cases:3.00%
controls:0.35%
—
5
15
987
9898
—
—
—
14
13
835
9217
13
22
420
6321
fluoxetine; oral
N06AB03 [21604711]
2.4e+00
2.2e+00
—
—
—
2.1e+00
-1.0e+50
cases:1.61%
controls:0.14%
cases:0.81%
controls:0.09%
—
—
—
—
—
—
cases:0.59%
controls:0.08%
cases:0.00%
controls:0.11%
16
14
976
9899
8
9
984
9904
—
—
—
5
7
844
9223
0
7
433
6336
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
6.5e-01
1.1e+00
1.9e+00
—
1.3e+00
1.0e+00
6.7e-01
cases:2.92%
controls:1.55%
cases:2.32%
controls:0.82%
cases:0.81%
controls:0.12%
—
—
cases:0.62%
controls:0.16%
cases:2.83%
controls:1.06%
cases:7.85%
controls:4.19%
29
154
963
9759
23
81
969
9832
8
12
984
9901
—
6
16
964
9845
24
98
825
9132
34
266
399
6077
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
3.0e-01
1.1e+00
1.8e+00
—
2.2e+00
1.4e+00
6.5e-01
cases:2.92%
controls:2.18%
cases:2.32%
controls:0.80%
cases:0.60%
controls:0.10%
—
—
cases:0.62%
controls:0.07%
cases:2.59%
controls:0.68%
cases:4.16%
controls:2.22%
29
216
963
9697
23
79
969
9834
6
10
986
9903
—
6
7
964
9854
22
63
827
9167
18
141
415
6202
Open wound of head
S01 [45582756]
2.3e+00
—
—
—
—
—
2.3e+00
cases:0.81%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.14%
8
8
984
9905
—
—
—
—
—
6
9
427
6334
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
6.9e-01
7.5e-01
1.1e+00
—
1.3e+00
7.4e-01
3.5e-01
cases:16.23%
controls:8.90%
cases:10.18%
controls:5.06%
cases:2.02%
controls:0.70%
—
—
cases:2.89%
controls:0.78%
cases:11.54%
controls:5.86%
cases:20.79%
controls:15.58%
161
882
831
9031
101
502
891
9411
20
69
972
9844
—
28
77
942
9784
98
541
751
8689
90
988
343
5355
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.4e+00
1.6e+00
—
—
—
1.1e+00
1.5e+00
cases:2.12%
controls:0.52%
cases:1.31%
controls:0.27%
—
—
—
—
—
—
cases:0.94%
controls:0.30%
cases:3.46%
controls:0.76%
21
52
971
9861
13
27
979
9886
—
—
—
8
28
841
9202
15
48
418
6295
Open wound of head, part unspecified
S01.9 [45577864]
2.0e+00
—
—
—
—
—
2.5e+00
cases:0.60%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:2.08%
controls:0.17%
6
8
986
9905
—
—
—
—
—
9
11
424
6332
Retention of urine
R33 [45587507]
5.7e-01
1.1e+00
1.8e+00
—
1.9e+00
1.5e+00
7.5e-01
cases:3.13%
controls:1.79%
cases:2.12%
controls:0.71%
cases:0.60%
controls:0.10%
—
—
cases:1.03%
controls:0.16%
cases:3.06%
controls:0.67%
cases:5.31%
controls:2.59%
31
177
961
9736
21
70
971
9843
6
10
986
9903
—
10
16
960
9845
26
62
823
9168
23
164
410
6179
calcium (different salts in combination); oral
A12AA20 [21600872]
4.1e-01
5.6e-01
9.6e-01
1.4e+00
8.8e-01
7.6e-01
8.8e-01
cases:18.65%
controls:13.15%
cases:18.35%
controls:11.39%
cases:7.46%
controls:3.00%
cases:0.50%
controls:0.12%
cases:6.80%
controls:2.95%
cases:22.61%
controls:12.05%
cases:32.33%
controls:16.59%
185
1304
807
8609
182
1129
810
8784
74
297
918
9616
5
12
987
9901
66
291
904
9570
192
1112
657
8118
140
1052
293
5291
Vesical tenesmus
R30.1 [45602017]
1.7e+00
2.7e+00
—
—
—
—
—
cases:1.31%
controls:0.24%
cases:0.91%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
13
24
979
9889
9
6
983
9907
—
—
—
—
—
Extensive CT of head and brain
AA1BD [2001300110]
2.0e+00
—
—
—
—
2.4e+00
—
cases:0.60%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
—
—
6
8
986
9905
—
—
—
—
5
5
844
9225
—
Bacterial infection, unspecified
A49.9 [45590816]
5.8e-01
1.3e+00
1.4e+00
1.0e+50
—
1.8e+00
1.3e+00
cases:2.52%
controls:1.42%
cases:2.02%
controls:0.55%
cases:0.50%
controls:0.12%
cases:0.71%
controls:0.00%
—
—
cases:3.77%
controls:0.64%
cases:9.24%
controls:2.74%
25
141
967
9772
20
55
972
9858
5
12
987
9901
7
0
985
9913
—
32
59
817
9171
40
174
393
6169
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
3.2e-01
1.5e+00
—
—
—
1.6e+00
1.3e+00
cases:1.11%
controls:0.81%
cases:1.41%
controls:0.32%
—
—
—
—
—
—
cases:1.77%
controls:0.35%
cases:4.16%
controls:1.21%
11
80
981
9833
14
32
978
9881
—
—
—
15
32
834
9198
18
77
415
6266
Bullous pemphigoid
L12.0 [45533635]
2.2e+00
—
—
—
—
—
2.2e+00
cases:0.60%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.13%
6
7
986
9906
—
—
—
—
—
5
8
428
6335
Type 2 diabetes mellitus, with neurological complications
E11.4 [45576442]
2.2e+00
—
—
—
—
—
2.2e+00
cases:1.01%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.19%
10
11
982
9902
—
—
—
—
—
7
12
426
6331
Fracture: femur
L75 [2002000694]
1.3e+00
2.5e+00
—
—
—
—
1.9e+00
cases:0.50%
controls:0.14%
cases:0.71%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.25%
5
14
987
9899
7
6
985
9907
—
—
—
—
7
16
426
6327
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.4e-01
7.3e-01
1.8e+00
1.0e+50
8.2e-01
8.0e-01
5.9e-01
cases:12.50%
controls:8.45%
cases:6.45%
controls:3.22%
cases:2.32%
controls:0.40%
cases:0.81%
controls:0.00%
cases:1.03%
controls:0.46%
cases:6.01%
controls:2.78%
cases:15.94%
controls:9.48%
124
838
868
9075
64
319
928
9594
23
40
969
9873
8
0
984
9913
10
45
960
9816
51
257
798
8973
69
601
364
5742
Extensive global examination
SPAT1360 [2001700461]
1.0e+00
1.4e+00
—
—
—
1.6e+00
1.7e+00
cases:2.62%
controls:0.96%
cases:0.71%
controls:0.17%
—
—
—
—
—
—
cases:1.53%
controls:0.30%
cases:5.08%
controls:0.99%
26
95
966
9818
7
17
985
9896
—
—
—
13
28
836
9202
22
63
411
6280
Guidance concerning bowel function
SPAT1138 [2001700239]
1.9e+00
2.5e+00
—
—
—
—
—
cases:0.71%
controls:0.11%
cases:0.71%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
7
11
985
9902
7
6
985
9907
—
—
—
—
—
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
6.8e-01
7.7e-01
2.0e+00
—
—
7.8e-01
1.1e-02
cases:5.85%
controls:3.04%
cases:2.42%
controls:1.14%
cases:0.91%
controls:0.12%
—
—
—
—
cases:2.83%
controls:1.31%
cases:3.23%
controls:3.20%
58
301
934
9612
24
113
968
9800
9
12
983
9901
—
—
24
121
825
9109
14
203
419
6140
Influenza virus A+B Ag [Presence] in Specimen
24015-0 [3024891]
1.8e+00
2.5e+00
—
—
—
—
9.7e-01
cases:1.51%
controls:0.26%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.44%
15
26
977
9887
6
5
986
9908
—
—
—
—
5
28
428
6315
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
2.5e+00
—
—
—
—
—
1.7e+00
cases:1.11%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.35%
11
9
981
9904
—
—
—
—
—
8
22
425
6321
Chest pain, unspecified
R07.4 [45558450]
7.6e-01
8.2e-01
1.7e+00
—
—
8.5e-01
2.8e-01
cases:10.28%
controls:5.07%
cases:3.73%
controls:1.67%
cases:0.81%
controls:0.14%
—
—
—
—
cases:3.30%
controls:1.44%
cases:6.70%
controls:5.14%
102
503
890
9410
37
166
955
9747
8
14
984
9899
—
—
28
133
821
9097
29
326
404
6017
oxycodone and naloxone; oral
N02AA55 [21604265]
8.1e-01
6.9e-01
1.7e+00
—
1.5e+00
9.7e-01
6.6e-01
cases:6.15%
controls:2.83%
cases:2.32%
controls:1.18%
cases:0.91%
controls:0.16%
—
—
cases:0.62%
controls:0.14%
cases:3.18%
controls:1.22%
cases:7.39%
controls:3.96%
61
281
931
9632
23
117
969
9796
9
16
983
9897
—
6
14
964
9847
27
113
822
9117
32
251
401
6092
Dysphagia
R13 [45573013]
1.9e+00
1.0e+00
—
—
—
2.2e+00
1.2e+00
cases:3.43%
controls:0.52%
cases:0.81%
controls:0.29%
—
—
—
—
—
—
cases:1.41%
controls:0.15%
cases:2.31%
controls:0.71%
34
52
958
9861
8
29
984
9884
—
—
—
12
14
837
9216
10
45
423
6298
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.9e-01
1.2e+00
1.4e+00
—
2.1e+00
6.9e-01
5.3e-01
cases:6.15%
controls:2.88%
cases:4.64%
controls:1.39%
cases:0.71%
controls:0.17%
—
—
cases:1.13%
controls:0.14%
cases:2.94%
controls:1.51%
cases:7.16%
controls:4.35%
61
285
931
9628
46
138
946
9775
7
17
985
9896
—
11
14
959
9847
25
139
824
9091
31
276
402
6067
Observation for suspected nervous system disorder
Z03.3 [45609903]
2.2e+00
1.9e+00
—
—
—
1.8e+00
—
cases:2.32%
controls:0.26%
cases:0.81%
controls:0.12%
—
—
—
—
—
—
cases:0.59%
controls:0.10%
—
—
23
26
969
9887
8
12
984
9901
—
—
—
5
9
844
9221
—
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
8.6e-01
1.7e+00
—
—
—
1.6e+00
4.2e-01
cases:2.32%
controls:1.00%
cases:2.02%
controls:0.38%
—
—
—
—
—
—
cases:2.36%
controls:0.51%
cases:3.00%
controls:1.99%
23
99
969
9814
20
38
972
9875
—
—
—
20
47
829
9183
13
126
420
6217
Leukocytes [Presence] in Urine
33052-2 [3045414]
7.4e-01
9.5e-01
2.2e+00
—
1.9e+00
9.6e-01
4.6e-01
cases:1.41%
controls:0.68%
cases:2.02%
controls:0.79%
cases:0.60%
controls:0.07%
—
—
cases:0.62%
controls:0.09%
cases:2.71%
controls:1.05%
cases:5.31%
controls:3.41%
14
67
978
9846
20
78
972
9835
6
7
986
9906
—
6
9
964
9852
23
97
826
9133
23
216
410
6127
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
8.5e-01
1.7e+00
—
—
—
1.5e+00
5.8e-01
cases:2.22%
controls:0.96%
cases:1.81%
controls:0.34%
—
—
—
—
—
—
cases:2.12%
controls:0.47%
cases:3.23%
controls:1.83%
22
95
970
9818
18
34
974
9879
—
—
—
18
43
831
9187
14
116
419
6227
ferrous sulfate; oral
B03AA07 [21601086]
1.8e+00
—
—
—
—
2.2e+00
1.8e+00
cases:0.81%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:1.39%
controls:0.24%
8
13
984
9900
—
—
—
—
6
7
843
9223
6
15
427
6328
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
5.9e-01
6.5e-01
2.0e-02
—
1.5e+00
5.8e-01
7.3e-01
cases:7.96%
controls:4.57%
cases:4.64%
controls:2.47%
cases:0.50%
controls:0.49%
—
—
cases:1.96%
controls:0.45%
cases:4.95%
controls:2.83%
cases:12.93%
controls:6.65%
79
453
913
9460
46
245
946
9668
5
49
987
9864
—
19
44
951
9817
42
261
807
8969
56
422
377
5921
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.7e-01
9.2e-01
1.7e+00
1.0e+50
—
8.1e-01
6.3e-01
cases:8.17%
controls:6.39%
cases:5.65%
controls:2.33%
cases:1.71%
controls:0.32%
cases:0.60%
controls:0.00%
—
—
cases:4.48%
controls:2.05%
cases:11.55%
controls:6.53%
81
633
911
9280
56
231
936
9682
17
32
975
9881
6
0
986
9913
—
38
189
811
9041
50
414
383
5929
Lumbar spine and sacrum CT examination
NA3AD [2001307027]
1.7e+00
1.8e+00
—
—
—
—
2.3e+00
cases:1.01%
controls:0.18%
cases:0.50%
controls:0.08%
—
—
—
—
—
—
—
—
cases:2.31%
controls:0.24%
10
18
982
9895
5
8
987
9905
—
—
—
—
10
15
423
6328
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.6e+00
2.4e+00
—
—
—
—
—
cases:1.51%
controls:0.30%
cases:1.21%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
15
30
977
9883
12
11
980
9902
—
—
—
—
—
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.4e-01
7.7e-01
1.2e+00
—
1.8e+00
6.8e-01
7.5e-01
cases:6.35%
controls:5.58%
cases:4.54%
controls:2.15%
cases:1.01%
controls:0.30%
—
—
cases:2.37%
controls:0.41%
cases:3.89%
controls:2.02%
cases:9.01%
controls:4.46%
63
553
929
9360
45
213
947
9700
10
30
982
9883
—
23
40
947
9821
33
186
816
9044
39
283
394
6060
budesonide; oral, sublingual
A07EA06 [21600658]
—
—
—
—
2.3e+00
1.6e+00
1.1e+00
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.06%
controls:0.21%
cases:1.39%
controls:0.47%
—
—
—
—
5
5
965
9856
9
19
840
9211
6
30
427
6313
Therapeutic discussion
SPAT1240 [2001700341]
1.6e+00
—
—
—
—
2.4e+00
1.2e+00
cases:1.81%
controls:0.38%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
cases:1.39%
controls:0.44%
18
38
974
9875
—
—
—
—
5
5
844
9225
6
28
427
6315
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
2.1e+00
1.9e+00
-1.0e+50
—
—
—
—
cases:3.02%
controls:0.38%
cases:0.71%
controls:0.11%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
30
38
962
9875
7
11
985
9902
0
5
992
9908
—
—
—
—
Supplier / Service Provider
OMOP5117446 [33004]
1.7e-02
-9.1e-02
1.1e-01
—
—
1.8e+00
2.1e+00
cases:20.16%
controls:19.89%
cases:4.94%
controls:5.39%
cases:0.50%
controls:0.45%
—
—
—
—
cases:3.06%
controls:0.53%
cases:9.93%
controls:1.28%
200
1972
792
7941
49
534
943
9379
5
45
987
9868
—
—
26
49
823
9181
43
81
390
6262
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
5.7e-01
8.6e-01
1.7e+00
—
1.4e+00
7.6e-01
6.2e-01
cases:3.33%
controls:1.92%
cases:2.62%
controls:1.13%
cases:0.91%
controls:0.17%
—
—
cases:0.72%
controls:0.17%
cases:3.06%
controls:1.45%
cases:9.01%
controls:5.06%
33
190
959
9723
26
112
966
9801
9
17
983
9896
—
7
17
963
9844
26
134
823
9096
39
321
394
6022
Gas panel - Capillary blood
24337-8 [3022313]
1.4e+00
1.5e+00
—
—
—
8.9e-01
1.0e+00
cases:2.12%
controls:0.55%
cases:1.41%
controls:0.31%
—
—
—
—
—
—
cases:0.94%
controls:0.39%
cases:3.23%
controls:1.20%
21
55
971
9858
14
31
978
9882
—
—
—
8
36
841
9194
14
76
419
6267
olanzapine; oral, parenteral
N05AH03 [21604543]
—
—
1.0e+50
—
—
1.0e+50
3.9e+00
—
—
—
—
cases:0.60%
controls:0.00%
—
—
—
—
cases:1.65%
controls:0.00%
cases:3.70%
controls:0.08%
—
—
6
0
986
9913
—
—
14
0
835
9230
16
5
417
6338
clopidogrel; oral
B01AC04 [21600989]
6.2e-01
9.0e-01
9.4e-01
—
1.4e+00
9.1e-01
1.9e-01
cases:7.76%
controls:4.33%
cases:4.74%
controls:1.98%
cases:1.21%
controls:0.47%
—
—
cases:1.44%
controls:0.34%
cases:4.36%
controls:1.81%
cases:4.85%
controls:4.04%
77
429
915
9484
47
196
945
9717
12
47
980
9866
—
14
34
956
9827
37
167
812
9063
21
256
412
6087
Instability of the detrusor vesicae muscle
N32.82 [2000503170]
1.9e+00
—
—
—
—
2.0e+00
1.8e+00
cases:1.11%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.10%
cases:1.15%
controls:0.19%
11
17
981
9896
—
—
—
—
6
9
843
9221
5
12
428
6331
Pertrochanteric fracture
S72.1 [45574361]
—
1.4e+00
—
—
—
2.1e+00
1.7e+00
—
—
cases:0.60%
controls:0.15%
—
—
—
—
—
—
cases:1.65%
controls:0.20%
cases:2.08%
controls:0.39%
—
6
15
986
9898
—
—
—
14
18
835
9212
9
25
424
6318
oxycodone; oral, parenteral
N02AA05 [21604260]
8.5e-01
5.4e-01
7.4e-01
—
8.7e-01
1.2e+00
1.7e+00
cases:4.23%
controls:1.86%
cases:1.92%
controls:1.13%
cases:0.91%
controls:0.43%
—
—
cases:1.13%
controls:0.48%
cases:6.01%
controls:1.83%
cases:21.71%
controls:4.64%
42
184
950
9729
19
112
973
9801
9
43
983
9870
—
11
47
959
9814
51
169
798
9061
94
294
339
6049
Postmenopausal osteoporosis with pathological fracture
M80.0 [45572553]
6.6e-01
1.7e+00
—
—
—
2.0e+00
1.8e+00
cases:0.60%
controls:0.31%
cases:0.60%
controls:0.11%
—
—
—
—
—
—
cases:0.82%
controls:0.11%
cases:1.85%
controls:0.32%
6
31
986
9882
6
11
986
9902
—
—
—
7
10
842
9220
8
20
425
6323
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
1.1e+00
1.4e+00
—
—
—
1.3e+00
6.5e-01
cases:1.92%
controls:0.68%
cases:1.31%
controls:0.32%
—
—
—
—
—
—
cases:1.65%
controls:0.43%
cases:3.93%
controls:2.10%
19
67
973
9846
13
32
979
9881
—
—
—
14
40
835
9190
17
133
416
6210

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
421
1779
3.37
74.09
2.9
1.8
298.16
184.15
u/l
1.80
398
1644
350
1355
3.45
70.44
2.1
1.6
1081.70
1136.62
nmol/l
0.51
248
989
490
2475
2.94
60.18
4.9
3.1
—
—
—
0
0
707
4945
2.50
37.01
7.8
4.4
4081.26
3328.19
e6/l
0.08
23
72
430
2433
2.35
36.84
4.3
4.2
—
—
—
0
0
406
2276
2.33
35.15
2.0
1.7
16.87
19.67
nmol/l
3.85
362
1833
538
3528
2.15
30.19
2.6
2.1
82.81
92.71
pmol/l
6.89
340
1785
31
27
11.82
30.15
1.3
1.1
1.74
25.89
e6/l
0.58
23
19
31
28
11.40
29.45
1.6
1.2
226.84
19.14
e6/l
0.57
25
21
35
39
9.27
28.73
4.8
3.1
—
—
—
0
0
582
4005
2.10
27.89
5.6
7.3
1.21
1.21
mmol/l
1.80
482
3422
294
1559
2.26
27.85
1.9
1.7
384.57
22097199.55
pmol/l
1.30
238
1240
32
36
9.15
26.06
1.4
1.2
—
—
—
0
0
452
2916
2.01
24.95
5.6
3.8
46.41
74.20
ng/l
1.20
386
2362
353
2189
1.95
20.95
2.2
2.3
2.68
2.96
mg/l
1.65
278
1849
605
4470
1.91
20.91
5.2
4.6
6.39
6.89
mmol/l
12.14
585
4235
533
3788
1.88
20.72
6.0
3.7
10.28
4.43
estimate
0.24
145
897
510
3577
1.88
20.64
4.9
6.4
1.20
1.20
mmol/l
0.14
461
3296
534
3833
1.85
19.76
6.0
3.8
0.03
0.00
estimate
0.44
141
832
71
215
3.48
19.75
2.0
2.4
383.00
433.57
ug/l
0.13
66
209
373
2396
1.89
19.62
4.1
3.3
0.54
0.56
e6/l
0.05
295
1794
435
2943
1.85
19.35
4.7
3.3
6.31
6.24
ph
0.64
239
1565
521
3728
1.84
19.31
6.0
3.7
0.00
0.00
estimate
-0.00
140
861
283
1689
1.95
18.38
4.1
3.0
603.67
542.65
mosm/kgh2o
5.22
249
1461
407
2742
1.82
18.00
4.3
3.4
44.62
141.79
e6/l
1.31
327
2118
369
2428
1.83
17.53
2.7
4.4
7.41
7.40
ph
7.02
283
1733
499
3600
1.78
17.30
3.7
5.1
33.88
34.07
g/l
0.29
446
3327
342
2207
1.84
17.25
4.1
3.3
0.70
1096.88
estimate
—
5
14
407
2773
1.79
17.11
6.3
3.9
0.03
0.02
estimate
0.02
117
699
174
2960
0.50
15.35
3.0
3.4
47.46
49.49
mg/l
0.05
113
1905
175
2965
0.50
15.22
3.1
3.3
7.16
7.07
mmol/l
0.12
138
2419
160
2781
0.49
14.98
1.6
1.9
1.07
1.22
mmol/l
3.08
133
2206
422
3002
1.71
14.59
5.1
3.9
130.15
152.05
e6/l
0.24
331
2179
417
2962
1.70
14.46
2.3
2.2
71.83
81.38
nmol/l
10.42
344
2561
296
1922
1.77
14.09
6.1
3.5
0.01
0.01
estimate
0.10
110
623
228
1372
1.86
13.95
3.7
3.3
2.39
1.65
e6/l
0.73
125
755
523
3992
1.66
13.45
14.9
19.5
1.31
1.39
inr
2.42
452
3349
107
504
2.26
12.80
1.6
2.6
409.19
413.37
nmol/l
0.07
84
469
235
1474
1.78
12.38
3.7
3.2
1.05
1.07
e6/l
0.02
134
854
195
3035
0.56
12.09
3.9
4.1
7.02
8.81
mg/mmol
0.41
125
1890
284
1890
1.70
12.09
3.3
2.6
4.99
4.93
e6/l
0.03
260
1689
600
4840
1.61
11.56
3.9
3.8
15.52
15.20
pmol/l
2.03
518
4207
37
107
3.55
11.07
1.5
2.5
23.67
34.81
umol/l
3.57
30
99
308
2155
1.62
10.56
6.0
3.7
0.00
0.01
estimate
0.78
116
750
241
1599
1.67
10.13
5.5
3.8
1.02
1.02
kg/l
1.30
171
1094
396
2979
1.55
9.78
2.6
3.0
159.91
182.03
ug/l
0.85
335
2692
268
1861
1.60
9.29
4.6
3.1
0.08
0.00
0.47
13
78
13
7
18.79
8.94
1.1
1.1
131.69
120.71
nmol/l
—
13
7
54
222
2.51
8.77
4.9
4.5
25.64
24.73
mmol/l
1.34
45
193
169
1061
1.71
8.62
2.0
2.0
29.73
30.28
s
0.61
160
1034
96
506
1.99
8.56
4.1
4.2
—
—
—
0
0
33
106
3.19
8.44
1.4
1.2
—
—
—
0
0
777
6877
1.60
8.36
26.9
17.2
30.65
30.98
mg/l
0.09
726
5662
116
660
1.86
8.24
2.8
4.4
1.22
1.22
mmol/l
0.12
95
571
14
12
11.81
8.09
1.4
1.2
—
—
—
0
0
197
1308
1.63
8.08
1.7
3.1
0.83
0.82
mmol/l
0.71
178
1227
120
698
1.82
7.94
2.5
2.3
5.93
7.07
ug/l
0.43
64
627
145
892
1.73
7.93
2.6
3.6
7.38
7.37
ph
1.25
96
552
97
539
1.89
7.42
5.3
5.8
25.30
24.17
mmol/l
2.28
91
515
445
3586
1.44
7.14
3.3
2.9
53.38
63.83
u/l
0.72
402
3189
224
1577
1.54
7.08
4.5
3.9
148.95
676.06
ng/l
2.62
205
1420
300
2253
1.48
6.94
2.6
2.4
53.34
63.09
u/l
1.93
276
2056
70
358
2.03
6.81
2.4
1.8
—
—
—
0
0
159
1042
1.63
6.81
4.3
6.4
1.75
0.74
mmol/l
3.52
133
845
62
1173
0.50
6.77
3.3
4.7
2.90
31.35
ug/l
3.05
46
1001
158
1039
1.62
6.67
4.3
6.5
7.42
7.41
ph
0.96
104
558
129
813
1.67
6.43
1.8
1.8
—
—
—
0
0
15
23
6.60
6.35
1.2
1.0
—
—
—
0
0
700
6195
1.44
6.28
5.3
4.6
1.93
2.19
mu/l
5.77
610
5389
18
47
3.88
6.28
1.3
1.1
326.36
336.61
nmol/l
0.06
11
33
134
861
1.64
6.20
2.7
3.6
2.50
1.59
mmol/l
2.47
118
714
156
1047
1.58
6.03
4.3
6.5
11.53
12.01
kpa
0.54
148
1004
156
1047
1.58
6.03
4.3
6.5
5.08
5.06
kpa
0.09
149
1001
170
1164
1.56
6.02
1.7
2.3
1.57
1.74
%
1.80
139
1024
339
2663
1.41
6.00
2.3
4.1
2.33
2.35
mmol/l
1.10
299
2351
78
439
1.84
5.76
4.3
4.2
7.43
7.42
ph
0.89
66
363
79
447
1.83
5.73
4.3
4.2
5.21
5.08
kpa
0.61
70
421
225
1652
1.47
5.70
2.6
3.5
2.46
2.47
mmol/l
1.53
195
1453
658
5805
1.40
5.67
5.7
8.6
82.90
85.33
u/l
0.47
595
5437
100
610
1.71
5.63
7.4
3.7
—
—
—
0
0
51
251
2.09
5.54
3.9
3.5
1.61
1.68
mmol/l
0.18
51
246
5
0
+∞
5.21
11.6
0.0
0.74
—
mmol/l
—
5
0
35
155
2.30
4.94
3.3
4.6
1.85
2.67
mmol/l
1.19
26
102
485
4141
1.33
4.79
3.8
7.3
12.17
13.64
umol/l
2.09
448
3949
135
931
1.52
4.60
4.3
6.8
95.80
95.19
%
0.78
129
899
602
6676
0.75
4.53
4.1
5.1
1.41
1.44
mmol/l
0.98
516
5883
47
245
1.96
4.42
6.3
5.3
1.08
1.41
mmol/l
2.37
42
224
405
3398
1.32
4.40
5.2
6.2
8.57
9.34
%
5.98
369
3160
315
2551
1.34
4.35
4.9
5.9
—
—
—
0
0
404
3394
1.32
4.33
4.9
6.1
2.44
2.85
%
3.55
368
3160
10
341
0.29
4.27
1.0
1.2
—
—
—
0
0
611
6740
0.76
4.26
4.1
5.2
4.19
4.39
mmol/l
5.05
526
5994
54
302
1.83
4.13
5.0
4.4
—
—
—
0
0
200
1521
1.39
4.08
1.8
2.6
11.29
11.93
umol/l
0.78
171
1424
403
3408
1.31
4.04
5.1
6.1
0.57
0.65
%
2.84
365
3171
398
3362
1.31
4.02
5.2
6.0
62.95
59.06
%
8.76
370
3189
190
1437
1.40
4.00
1.8
2.6
2.13
2.23
g/l
1.30
156
1333
10
18
5.60
3.98
1.0
1.9
64.03
54.22
ug/l
—
10
18
575
6371
0.77
3.97
3.6
4.3
1.11
1.22
mmol/l
4.21
481
5538
51
870
0.56
3.95
1.1
1.4
—
—
—
0
0
432
3700
1.30
3.90
5.1
5.8
1.56
1.82
e9/l
4.19
378
3155
313
2577
1.31
3.76
2.3
2.8
—
—
—
0
0
111
767
1.50
3.76
1.7
2.1
0.20
0.19
g/l
0.42
99
711
405
3453
1.29
3.74
5.2
6.1
22.27
25.38
%
7.34
378
3243
434
3734
1.29
3.74
5.2
5.9
0.16
0.20
e9/l
6.51
372
3131
0
95
0.00
3.68
0.0
1.1
—
—
—
0
0
84
555
1.56
3.50
4.2
2.8
5.95
5.95
ph
0.01
64
415
126
914
1.43
3.35
1.8
2.4
59.55
66.59
e9/l
1.57
94
678
419
3625
1.27
3.34
4.9
5.8
0.59
0.64
e9/l
3.65
355
3001
186
1444
1.35
3.31
1.7
1.5
1.56
1.87
mg/l
0.48
148
1144
419
3642
1.26
3.17
4.9
5.8
0.04
0.04
e9/l
4.54
355
3017
115
831
1.43
3.13
2.9
2.8
198.43
287.41
ng/l
1.43
106
762
641
6926
0.79
3.10
4.8
6.1
2.36
2.52
mmol/l
5.04
549
6137
19
80
2.40
3.07
3.0
1.9
0.89
0.68
u/field
—
9
34
411
3583
1.25
2.98
2.7
3.1
—
—
estimate
—
0
0
237
1936
1.29
2.94
3.7
3.9
78.82
81.35
%
0.89
232
1894
100
714
1.45
2.91
2.8
2.4
0.65
0.43
e6/l
0.40
100
695
173
1360
1.33
2.83
1.9
2.5
21.57
21.70
%
0.04
145
1265
752
7041
1.28
2.82
24.2
16.1
—
—
—
0
0
87
610
1.47
2.79
3.6
3.0
—
—
—
0
0
47
286
1.68
2.77
7.8
3.9
—
—
—
0
0
187
2290
0.77
2.56
2.8
3.7
0.76
0.90
ug/l
0.99
129
1694
38
621
0.60
2.56
1.8
2.1
11.92
12.12
nmol/l
0.05
30
528
101
741
1.40
2.55
5.1
4.6
7.36
7.35
ph
0.03
72
522
141
1097
1.33
2.48
1.2
1.2
0.62
1.88
u/ml
2.29
32
242
84
603
1.43
2.41
1.6
3.0
—
—
—
0
0
62
419
1.51
2.40
1.9
1.8
1.37
1.87
ug/l
0.35
43
373
261
3052
0.80
2.39
2.2
2.4
—
—
—
0
0
34
557
0.60
2.33
1.4
1.4
—
—
—
0
0
43
269
1.63
2.32
1.5
1.2
—
—
—
0
0
344
3005
1.22
2.32
3.2
3.2
1462.76
1987.74
ng/l
1.78
297
2680
11
40
2.77
2.28
1.1
1.1
—
—
—
0
0
12
47
2.57
2.27
1.3
1.2
—
—
—
0
0
781
7409
1.25
2.25
31.1
21.5
139.81
139.56
mmol/l
1.69
764
7205
29
489
0.58
2.23
1.3
1.4
—
—
—
0
0
27
463
0.57
2.21
1.5
1.6
—
—
—
0
0
781
7413
1.25
2.21
31.1
21.8
3.96
4.03
mmol/l
9.58
763
7201
110
843
1.34
2.15
1.8
2.7
9.58
12.98
umol/l
0.80
95
743
251
2143
1.23
2.09
2.2
3.0
36.85
38.22
u/l
0.07
229
1991
10
37
2.72
2.07
1.6
1.5
—
—
—
0
0
26
441
0.58
2.06
2.2
3.5
108.36
6506.86
u/ml
1.39
21
377
28
162
1.75
2.04
1.4
1.5
23405.11
14408.15
e6/l
0.27
19
115
68
931
0.71
2.00
1.2
1.2
68.83
45.43
iu/ml
0.35
25
282
31
186
1.69
1.99
2.5
3.7
—
—
—
0
0
162
1960
0.79
1.98
4.1
3.8
—
—
—
0
0
463
4208
1.19
1.97
6.4
10.1
4.71
4.36
e9/l
1.88
395
3570
91
688
1.36
1.96
2.6
2.0
0.00
0.02
estimate
0.50
16
135
48
695
0.67
1.93
1.3
1.3
247.27
553.54
titre
2.77
11
161
23
128
1.82
1.91
1.4
1.7
2.37
4.57
iu/l
—
7
40
87
665
1.34
1.77
2.2
2.4
30.72
38.73
u/l
0.78
68
556
601
5615
1.18
1.76
30.4
22.9
13.78
14.01
%
4.44
591
5497
21
358
0.58
1.73
1.3
1.3
—
—
—
0
0
781
7471
1.21
1.73
32.1
24.6
73.82
87.82
umol/l
51.28
765
7329
27
163
1.67
1.73
1.2
1.8
0.69
0.82
%
1.09
17
113
5
13
3.86
1.71
1.6
2.1
62.40
665.31
nmol/24h
—
5
13
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
0
48
0.00
1.70
0.0
2.3
—
36.43
—
0
48
783
7497
1.21
1.69
36.4
27.0
4.20
4.37
e12/l
18.10
756
7204
783
7497
1.21
1.69
36.8
27.5
37.92
39.39
%
10.59
764
7333
783
7497
1.21
1.69
36.4
26.9
92.33
92.09
fl
0.80
764
7336
783
7497
1.21
1.69
36.4
26.9
30.54
30.52
pg
0.13
764
7337
783
7497
1.21
1.69
36.5
27.0
232.45
234.35
e9/l
0.37
757
7243
783
7498
1.21
1.68
36.5
27.0
6.95
6.94
e9/l
0.05
755
7202
783
7498
1.21
1.68
36.8
27.2
126.71
132.34
g/l
24.39
764
7343
576
5378
1.17
1.66
31.2
24.3
330.42
330.85
g/l
0.54
562
5328
6
148
0.40
1.64
1.2
1.4
—
—
—
0
0
42
286
1.49
1.64
2.3
2.5
—
24.05
—
0
25
29
183
1.60
1.58
6.8
3.1
21.09
29.53
mg/l
1.11
24
136
20
115
1.75
1.53
1.2
1.2
—
—
—
0
0
13
65
2.01
1.49
1.5
1.2
275.25
274.57
mosm/kgh2o
—
8
46
67
870
0.75
1.45
1.3
1.2
12.66
21.08
u/ml
0.46
24
267
174
2019
0.83
1.41
2.1
3.1
334.65
370.69
umol/l
3.59
136
1711
0
38
0.00
1.34
0.0
1.4
—
51507.09
—
0
22
0
38
0.00
1.34
0.0
2.1
—
0.48
—
0
38
0
39
0.00
1.34
0.0
1.6
—
529.89
—
0
28
45
327
1.39
1.30
2.0
2.2
0.00
0.12
estimate
0.56
16
95
131
1100
1.22
1.30
2.5
5.5
0.97
1.05
mmol/l
3.85
119
1026
21
329
0.63
1.29
1.2
1.8
—
30.12
—
0
9
72
566
1.29
1.26
2.2
2.0
197.64
150.96
ug/g
0.55
55
437
62
793
0.77
1.23
1.4
1.3
—
—
—
0
0
11
57
1.94
1.17
1.4
2.1
16.75
15.38
%
0.77
11
57
0
34
0.00
1.16
0.0
1.7
—
—
—
0
0
0
36
0.00
1.14
0.0
2.4
—
63.61
—
0
36
57
446
1.29
1.06
2.5
2.4
—
—
—
0
0
29
204
1.43
1.04
1.4
1.4
307.00
251.57
ug/g
0.56
18
130
62
773
0.79
1.03
1.2
1.4
—
—
—
0
0
102
1205
0.83
1.03
1.4
1.4
—
—
—
0
0
39
290
1.36
1.03
2.4
3.3
4.33
4.35
pmol/l
0.05
31
251
23
155
1.50
1.01
1.1
1.1
—
—
—
0
0
5
108
0.46
1.01
1.0
1.1
—
—
—
0
0
32
231
1.40
1.00
2.1
3.3
3.07
1.56
index
0.55
15
111
18
273
0.65
1.00
1.2
1.3
—
—
—
0
0
95
797
1.21
0.99
1.5
3.1
65.68
65.67
g/l
0.00
75
734
127
1098
1.18
0.96
1.8
1.9
—
—
—
0
0
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
9
51
1.77
0.94
1.3
2.0
11.27
8.38
mmol/l
—
9
51
73
599
1.24
0.94
2.6
3.5
78.04
100.41
ng/l
1.74
56
515
6
120
0.50
0.93
1.0
1.2
—
—
—
0
0
10
168
0.59
0.87
1.1
1.6
0.22
0.22
g/l
—
10
158
46
579
0.78
0.86
1.3
1.4
—
—
—
0
0
644
6674
0.90
0.85
6.7
7.0
39.76
40.21
mmol/mol
0.66
562
5994
27
196
1.39
0.85
12.8
11.4
—
—
—
0
0
14
88
1.60
0.84
1.6
1.1
—
—
—
0
0
11
65
1.70
0.82
2.1
1.5
—
—
—
0
0
0
25
0.00
0.79
0.0
2.3
—
30.20
—
0
25
0
25
0.00
0.79
0.0
2.3
—
5.40
—
0
25
553
5299
1.10
0.77
4.8
4.6
—
0.25
—
0
16
11
172
0.64
0.74
1.1
1.6
1.15
1.10
g/l
0.29
11
161
9
56
1.61
0.72
1.9
2.1
291.22
281.57
mu/l
—
9
56
14
206
0.68
0.72
1.2
1.5
33.08
30.37
g/l
0.34
14
192
5
94
0.53
0.67
1.2
2.5
356.40
827.00
mg
—
5
94
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
16
112
1.44
0.63
1.4
1.3
—
—
—
0
0
26
199
1.31
0.63
1.6
1.6
33.94
31.84
u/ml
—
7
38
12
79
1.53
0.62
1.2
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
10
150
0.66
0.58
1.3
1.6
—
—
—
0
0
6
35
1.72
0.57
1.2
3.5
1.00
0.83
index
—
6
35
10
65
1.54
0.55
1.5
1.8
9.56
10.23
%
—
10
65
36
438
0.82
0.55
1.2
1.3
—
—
—
0
0
12
82
1.47
0.54
2.3
3.3
19.83
11.43
index
—
6
35
669
6855
0.93
0.53
5.0
5.7
6.01
6.08
mmol/l
0.70
562
5982
84
745
1.14
0.51
3.5
7.7
—
—
—
0
0
11
75
1.47
0.51
1.8
2.0
—
—
—
0
0
51
439
1.17
0.47
2.2
3.2
—
—
—
0
0
11
153
0.72
0.45
1.1
1.4
—
—
—
0
0
5
85
0.59
0.45
1.0
1.1
—
—
—
0
0
39
330
1.19
0.44
1.3
2.5
9.10
10.95
g/l
3.19
27
293
64
721
0.88
0.42
2.8
4.2
1.46
0.77
%
0.34
13
248
0
16
0.00
0.41
0.0
2.9
—
1981.13
—
0
16
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
0.48
—
0
6
0
17
0.00
0.40
0.0
1.6
—
47.21
—
0
11
35
297
1.18
0.40
2.5
3.3
140.43
290.16
mg/l
2.91
14
138
7
101
0.69
0.39
1.1
1.2
—
—
—
0
0
9
66
1.37
0.38
1.3
1.2
—
—
nmol/l
—
0
0
69
763
0.90
0.36
2.7
4.1
0.54
0.97
%
0.94
13
259
5
77
0.65
0.35
1.0
1.2
—
—
—
0
0
150
1406
1.08
0.35
4.1
4.7
—
—
—
0
0
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
6
45
1.34
0.33
1.5
1.8
—
—
—
0
0
17
210
0.81
0.33
1.8
2.4
34.20
86.53
ug/min
—
8
114
31
359
0.86
0.32
1.3
1.3
—
—
—
0
0
11
143
0.77
0.32
2.8
2.8
—
—
—
0
0
392
3806
1.05
0.30
4.5
6.8
2.88
4.92
ug/l
2.98
326
3384
34
388
0.87
0.30
1.4
1.2
—
—
—
0
0
11
141
0.78
0.29
1.1
1.4
—
—
—
0
0
10
77
1.30
0.26
1.1
1.6
19.50
29.77
ng/l
—
10
77
9
74
1.22
0.25
1.4
1.4
—
—
—
0
0
86
920
0.93
0.25
1.2
1.3
—
—
—
0
0
55
505
1.09
0.23
1.6
1.7
1.42
1.51
g/l
0.37
45
428
68
731
0.93
0.22
2.7
4.1
0.08
0.16
%
0.41
12
227
15
125
1.20
0.22
2.1
3.1
4.98
4.19
e9/l
0.45
15
125
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
10
80
1.25
0.20
1.4
1.2
0.54
0.22
nmol/l
—
5
5
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
48
1.25
0.20
2.5
2.4
—
—
—
0
0
345
3375
1.03
0.18
15.0
11.9
0.00
0.00
e9/l
4.36
279
2711
37
342
1.09
0.15
1.2
4.2
2.00
8.42
ratio
1.43
22
223
24
265
0.90
0.15
1.1
1.1
71.14
144.25
u/ml
—
7
76
10
118
0.85
0.14
1.7
1.8
—
—
—
0
0
29
267
1.09
0.13
1.2
4.6
—
—
—
0
0
742
7368
1.03
0.13
10.2
12.6
16.73
23.92
u/l
26.76
673
7011
15
169
0.89
0.12
1.5
1.6
8.89
12.78
mg/l
1.98
15
150
79
823
0.96
0.12
3.2
6.3
10.15
12.61
mmol/l
2.79
70
782
24
220
1.09
0.12
1.1
1.8
—
—
—
0
0
100
1034
0.96
0.11
1.2
1.6
2.26
3.04
g/l
3.25
43
583
201
2052
0.97
0.11
1.2
1.3
—
—
—
0
0
69
718
0.96
0.10
2.8
4.4
0.00
0.17
%
1.73
12
217
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
6
54
1.11
0.09
1.0
2.2
—
—
—
0
0
12
107
1.12
0.08
1.3
1.1
—
—
—
0
0
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
12
109
1.10
0.06
3.0
2.6
—
—
—
0
0
16
168
0.95
0.02
1.8
2.4
60.92
62.39
%
0.11
16
168
224
2250
0.99
0.01
6.3
6.8
—
—
—
0
0
84
832
1.01
0.01
2.8
3.1
4.80
4.58
e9/l
0.24
59
687
38
384
0.99
0.00
1.3
4.4
44.59
212.35
mg/l
0.66
28
338
15
152
0.99
0.00
2.2
3.3
57.40
58.11
%
0.07
15
152
38
383
0.99
0.00
1.3
4.4
45.87
64.85
mg/l
0.37
27
341
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
20.2
—
102.83
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
28.00
—
0
9
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
73.67
—
0
6
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
8
88
0.91
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.60
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
91
0.99
-0.00
2.6
2.8
—
—
—
0
0
7
70
1.00
-0.00
3.1
1.9
30.00
38.74
mg/l
—
7
50
0
5
0.00
-0.00
0.0
1.0
—
0.03
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint PD_DEMENTIA_EXMORE and mortality.

Females

Parameter HR [95% CI] p-value
PD_DEMENTIA_EXMORE 4.002 [3.47, 4.62] < 0.001
Birth year 0.996 [0.99, 1.0] 0.35

During the follow-up period (1.1.1998 — 31.12.2019), 2678 out of 3661 females with PD_DEMENTIA_EXMORE died.

Males

Parameter HR [95% CI] p-value
PD_DEMENTIA_EXMORE 4.506 [3.75, 5.41] < 0.001
Birth year 0.99 [0.98, 1.0] 0.032

During the follow-up period (1.1.1998 — 31.12.2019), 3543 out of 4687 males with PD_DEMENTIA_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have PD_DEMENTIA_EXMORE.

N-year risk Females Males
1 0.287% 1.034%
5 2.261% 5.714%
10 5.45% 13.843%
15 10.744% 24.757%
20 18.651% 38.964%

Relationships between endpoints

↥

Index endpoint: PD_DEMENTIA_EXMORE – Dementia due to Parkinsons disease, excluding more controls

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data